{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_0", "document_index": 65, "latency_s": 34.3651772000012, "prompt_toks": 17607, "completion_toks": 64}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Temazepam\n\nPubChem CID\n\n5391\n\nStructure\n\nTemazepam_small.png\n\nTemazepam_3D_Structure.png\n\nChemical Safety\n\nIrritant\n\nLaboratory Chemical Safety Summary (LCSS) Datasheet\n\nMolecular Formula\n\nC16H13ClN2O2\n\nSynonyms\n\ntemazepam\n\nRestoril\n\nHydroxydiazepam\n\nMethyloxazepam\n\nOxydiazepam\n\nMolecular Weight\n\n300.74 g/mol\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nDates\n\nCreate:\n\n2005-03-25\n\nModify:\n\n2025-04-19\n\nDescription\n\nTemazepam can cause developmental toxicity according to state or federal government labeling requirements.\n\nTemazepam is a benzodiazepine.\n\nTemazepam is a DEA Schedule IV controlled substance. Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III. It is a Depressants substance.\n\nContents\n\n1 Structures\n\n1.1 2D Structure\n\nChemical Structure Depiction\n\nTemazepam.png\n\n1.2 3D Conformer\n\n2 Names and Identifiers\n\n2.1 Computed Descriptors\n\n2.1.1 IUPAC Name\n\n7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one\n\n\n                    Context: \n                    This chunk is from the top summary section of the Temazepam PubChem compound page, providing key identifiers, chemical structure images, core chemical properties, common synonyms, molecular formula, molecular weight, safety notes, and a brief regulatory and descriptive overview before deeper sections on chemical properties, pharmacology, toxicity, and uses.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_1", "document_index": 65, "latency_s": 34.55998650001129, "prompt_toks": 17774, "completion_toks": 79}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Chemical Structure Depiction\n\nTemazepam.png\n\n1.2 3D Conformer\n\n2 Names and Identifiers\n\n2.1 Computed Descriptors\n\n2.1.1 IUPAC Name\n\n7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one\n\nComputed by Lexichem TK 2.7.0 (PubChem release 2021.10.14)\n\n2.1.2 InChI\n\nInChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3\n\nComputed by InChI 1.0.6 (PubChem release 2021.10.14)\n\n2.1.3 InChIKey\n\nSEQDDYPDSLOBDC-UHFFFAOYSA-N\n\nComputed by InChI 1.0.6 (PubChem release 2021.10.14)\n\n2.1.4 SMILES\n\nCN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3\n\nComputed by OEChem 2.3.0 (PubChem release 2024.12.12)\n\n2.2 Molecular Formula\n\nC16H13ClN2O2\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\n2.3 Other Identifiers\n\n2.3.1 CAS\n\n846-50-4\n\n2.3.2 European Community (EC) Number\n\n212-688-1\n\n2.3.3 UNII\n\nCHB1QD2QSS\n\n2.3.4 ChEBI ID\n\nCHEBI:9435\n\n2.3.5 ChEMBL ID\n\nCHEMBL967\n\n2.3.6 DEA Code Number\n\n2925 (DEA schedule IV controlled substance)\n\n2.3.7 DrugBank ID\n\n\n                    Context: \n                    This section provides detailed chemical identifiers and computed structural descriptors for temazepam, including its IUPAC name, InChI, InChIKey, SMILES, molecular formula, CAS number, and several major database and regulatory identifiers. It follows the chemical structure depictions and precedes comprehensive information on temazepam’s properties, safety, pharmacology, and uses in the full document.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_2", "document_index": 65, "latency_s": 35.82869039999787, "prompt_toks": 17752, "completion_toks": 113}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    212-688-1\n\n2.3.3 UNII\n\nCHB1QD2QSS\n\n2.3.4 ChEBI ID\n\nCHEBI:9435\n\n2.3.5 ChEMBL ID\n\nCHEMBL967\n\n2.3.6 DEA Code Number\n\n2925 (DEA schedule IV controlled substance)\n\n2.3.7 DrugBank ID\n\nDB00231\n\n2.3.8 DSSTox Substance ID\n\nDTXSID8021309\n\n2.3.9 HMDB ID\n\nHMDB0014376\n\n2.3.10 KEGG ID\n\nC07125\n\nD00370\n\n2.3.11 Metabolomics Workbench ID\n\n42633\n\n2.3.12 NCI Thesaurus Code\n\nC29488\n\n2.3.13 Nikkaji Number\n\nJ7.138B\n\n2.3.14 NSC Number\n\n246303\n\n2.3.15 PharmGKB ID\n\nPA451608\n\n2.3.16 Pharos Ligand ID\n\nQ4CA3TGL2PVD\n\n2.3.17 RXCUI\n\n10355\n\n2.3.18 Wikidata\n\nQ414796\n\n2.3.19 Wikipedia\n\nTemazepam\n\n2.4 Synonyms\n\n2.4.1 MeSH Entry Terms\n\n3 Hydroxydiazepam\n\n3-Hydroxydiazepam\n\nApo Temazepam\n\nApo-Temazepam\n\nDasuen\n\nEuhypnos\n\nGen Temazepam\n\nGen-Temazepam\n\nHydroxydiazepam\n\nLevanxol\n\nMethyloxazepam\n\nNocturne\n\nNorkotral Tema\n\nNormison\n\nNormitab\n\nNortem\n\nNovo Temazepam\n\nNovo-Temazepam\n\nNu Temazepam\n\nNu-Temazepam\n\nOxydiazepam\n\nPlanum\n\nPMS Temazepam\n\nPMS-Temazepam\n\nPronervon T\n\nRemestan\n\nRestoril\n\nRo 5 5345\n\nRo-5-5345\n\nRo55345\n\n\n                    Context: \n                    This chunk lists various database identifiers and registry numbers for temazepam—including UNII, ChEBI, ChEMBL, DrugBank, DSSTox, HMDB, KEGG, NCI Thesaurus, Nikkaji, NSC, PharmGKB, Pharos, RXCUI, Wikidata, and Wikipedia—immediately followed by synonym information sourced from MeSH. It is part of the \"Names and Identifiers\" section, providing standardized cross-references and alternative names for temazepam to support database searching and interoperability.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_3", "document_index": 65, "latency_s": 34.91753750000498, "prompt_toks": 17753, "completion_toks": 72}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Normitab\n\nNortem\n\nNovo Temazepam\n\nNovo-Temazepam\n\nNu Temazepam\n\nNu-Temazepam\n\nOxydiazepam\n\nPlanum\n\nPMS Temazepam\n\nPMS-Temazepam\n\nPronervon T\n\nRemestan\n\nRestoril\n\nRo 5 5345\n\nRo-5-5345\n\nRo55345\n\nSaH 47 603\n\nSaH 47-603\n\nSaH 47603\n\nSignopam\n\nTema, Norkotral\n\nTemaze\n\ntemazep von ct\n\nTemazepam\n\nTemtabs\n\nTenox\n\nVon Ct, Temazep\n\nWY 3917\n\nWY-3917\n\nWY3917\n\n2.4.2 Depositor-Supplied Synonyms\n\ntemazepam\n\nRestoril\n\nHydroxydiazepam\n\nMethyloxazepam\n\nOxydiazepam\n\nCrisonar\n\nLevanxene\n\nLevanxol\n\nN-Methyloxazepam\n\n846-50-4\n\nEuhypnos\n\nMabertin\n\nSignopam\n\n3-Hydroxydiazepam\n\nNormison\n\nRemestan\n\nCerepax\n\nEuipnos\n\nPlanum\n\nTemaz\n\nNocturne\n\nTemtabs\n\nTenox\n\nTemazepamum\n\nNomapam\n\nTemador\n\nLenal\n\nUvamin Retard\n\nNeodorm SP\n\nWy-3917\n\n(RS)-Temazepam\n\nER 115\n\nStrazepam\n\nRo 5-5345\n\nTemazepam civ\n\nTemazepamum [INN-Latin]\n\nWY 3917\n\nK-3917\n\n2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-\n\nTemazepam, pharmaceutical grade\n\nCCRIS 1954\n\nNSC 246303\n\nCHB1QD2QSS\n\nUNII-CHB1QD2QSS\n\nK3917\n\n\n                    Context: \n                    This chunk lists alternative names and synonyms for temazepam, including brand names, generic names, chemical names, and registry numbers. It is part of the \"Names and Identifiers\" section, specifically under \"Synonyms\" and \"Depositor-Supplied Synonyms,\" providing comprehensive reference terms used for temazepam in various databases and product formulations.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_4", "document_index": 65, "latency_s": 34.225276999990456, "prompt_toks": 17768, "completion_toks": 63}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    WY 3917\n\nK-3917\n\n2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-\n\nTemazepam, pharmaceutical grade\n\nCCRIS 1954\n\nNSC 246303\n\nCHB1QD2QSS\n\nUNII-CHB1QD2QSS\n\nK3917\n\nEINECS 212-688-1\n\nNSC-246303\n\nBRN 0759300\n\n(+/-)-Temazepam\n\nDTXSID8021309\n\n1,3-Dihydro-7-chloro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one\n\nNormitab\n\nDasuen\n\nNortem\n\nNorkotral Tema\n\ntemazep von ct\n\nPronervon T\n\nCHEBI:9435\n\nDTXCID301309\n\nTemazepam [USAN:USP:INN:BAN]\n\n5-25-02-00242 (Beilstein Handbook Reference)\n\nNSC246303\n\nNCGC00159440-02\n\nGelthix\n\nLevanzene\n\nPerdorm\n\nTEMAZEPAM (IARC)\n\nTEMAZEPAM [IARC]\n\nTemazepamum (INN-Latin)\n\nTEMAZEPAM (MART.)\n\nTEMAZEPAM [MART.]\n\n7-Chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one\n\n3 Hydroxydiazepam\n\nTEMAZEPAM CIV (USP-RS)\n\nTEMAZEPAM CIV [USP-RS]\n\nTEMAZEPAM (EP MONOGRAPH)\n\nTEMAZEPAM [EP MONOGRAPH]\n\nTEMAZEPAM (USP MONOGRAPH)\n\nTEMAZEPAM [USP MONOGRAPH]\n\nTemazepam (USAN:USP:INN:BAN)\n\nTemazepam (100?g/ml in Methanol)\n\n\n                    Context: \n                    This chunk is part of the extensive list of synonyms and depositor-supplied alternative names for temazepam found in section 2.4.2. It provides various chemical identifiers, trade names, registry numbers, and alternate spellings by which temazepam is referenced in scientific, regulatory, and pharmaceutical contexts.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_5", "document_index": 65, "latency_s": 34.950578499992844, "prompt_toks": 17768, "completion_toks": 68}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    TEMAZEPAM CIV [USP-RS]\n\nTEMAZEPAM (EP MONOGRAPH)\n\nTEMAZEPAM [EP MONOGRAPH]\n\nTEMAZEPAM (USP MONOGRAPH)\n\nTEMAZEPAM [USP MONOGRAPH]\n\nTemazepam (USAN:USP:INN:BAN)\n\nTemazepam (100?g/ml in Methanol)\n\nTemazepam (1.0 mg/mL in Methanol)\n\n7-chloro-3-hydroxy-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one\n\nRestoril (TN)\n\nCAS-846-50-4\n\nTemazepam (USP/INN)\n\n7-chloro-3-hydroxy-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one\n\nDEA No. 2925\n\nDiazepam, 3-hydroxy\n\nWY 2917\n\nTEMAZEPAM [INN]\n\nTEMAZEPAM [MI]\n\nTEMAZEPAM [USAN]\n\nTEMAZEPAM [VANDF]\n\nCHEMBL967\n\nTEMAZEPAM [WHO-DD]\n\nSCHEMBL29463\n\nMLS003899242\n\nDivK1c_000989\n\nTemazepam, analytical standard\n\nTemazepam, 1mg/ml in Methanol\n\nGTPL7300\n\nTEMAZEPAM [ORANGE BOOK]\n\nHMS503E19\n\nKBio1_000989\n\nN05CD07\n\nNINDS_000989\n\nTemazepam 1.0 mg/ml in Methanol\n\nTox21_111670\n\nTox21_200044\n\nBDBM50408032\n\nCCG-213642\n\nDB00231\n\nRo-5-5354\n\nIDI1_000989\n\nNCGC00159440-03\n\nNCGC00257598-01\n\nSMR000238146\n\nWLN: T67 GNV JN IHJ CG G1 IQ KR\n\nNS00010416\n\nC07125\n\nD00370\n\nAB01563160_01\n\n\n                    Context: \n                    This chunk is part of the extensive synonyms and identifier section for temazepam, listing alternative names, registry numbers, chemical identifiers, and references across various pharmacopoeias, regulatory agencies, databases, and product formulations. It helps users cross-reference temazepam under different nomenclatures and standards in scientific, regulatory, and commercial contexts.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_6", "document_index": 65, "latency_s": 35.18636809999589, "prompt_toks": 17759, "completion_toks": 71}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Tox21_200044\n\nBDBM50408032\n\nCCG-213642\n\nDB00231\n\nRo-5-5354\n\nIDI1_000989\n\nNCGC00159440-03\n\nNCGC00257598-01\n\nSMR000238146\n\nWLN: T67 GNV JN IHJ CG G1 IQ KR\n\nNS00010416\n\nC07125\n\nD00370\n\nAB01563160_01\n\nQ414796\n\nBRD-A93093700-001-02-9\n\nTemazepam, British Pharmacopoeia (BP) Reference Standard\n\n2H-1, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-\n\nTemazepam, United States Pharmacopeia (USP) Reference Standard\n\nTemazepam; T8275_Sigma; Divk1c_000989; Ninds_000989\n\n1-methyl-7-chloro-3-hydroxy-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-one\n\n2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-3-hydroxy-1-methyl-5-phenyl-\n\n3-hydroxy-1,3-dihydro-1-methyl-7-chloro-5-phenyl-2H-1,4-benzodiazepin-2-one\n\n7-Chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one;\n\n7-Chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one #\n\n7-chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one\n\n\n                    Context: \n                    This chunk is part of an extensive list of synonyms and alternative names for temazepam, including registry numbers, chemical names, reference standards, and identifiers used in various chemical databases and pharmacopeias. It appears within the \"2.4 Synonyms\" section, providing comprehensive nomenclature information to support identification across scientific, regulatory, and commercial sources.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_7", "document_index": 65, "latency_s": 34.84208870001021, "prompt_toks": 17669, "completion_toks": 53}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    7-Chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one #\n\n7-chloro-3-hydroxy-1-methyl-5-phenyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one\n\n10-chloro-4-hydroxy-6-methyl-2-phenyl-3,6-diazabicyclo(5.4.0)undeca-2,8,10,12-tetraen-5-one\n\n212-688-1\n\n3 Chemical and Physical Properties\n\n3.1 Computed Properties\n\nProperty Name\n\nProperty Value\n\nReference\n\nProperty Name\n\nMolecular Weight\n\nProperty Value\n\n300.74 g/mol\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nXLogP3\n\nProperty Value\n\n2.2\n\nReference\n\nComputed by XLogP3 3.0 (PubChem release 2021.10.14)\n\nProperty Name\n\nHydrogen Bond Donor Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nHydrogen Bond Acceptor Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nRotatable Bond Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\n\n                    Context: \n                    This chunk is from the section listing alternative chemical names and identifiers for temazepam, immediately followed by the start of the \"Chemical and Physical Properties\" section, which provides computed physicochemical data such as molecular weight, logP, and hydrogen bonding characteristics.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_8", "document_index": 65, "latency_s": 35.58098950001295, "prompt_toks": 17594, "completion_toks": 88}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Computed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nRotatable Bond Count\n\nProperty Value\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nExact Mass\n\nProperty Value\n\n300.0665554 Da\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nMonoisotopic Mass\n\nProperty Value\n\n300.0665554 Da\n\nReference\n\nComputed by PubChem 2.2 (PubChem release 2021.10.14)\n\nProperty Name\n\nTopological Polar Surface Area\n\nProperty Value\n\n52.9 Å²\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nHeavy Atom Count\n\nProperty Value\n\n21\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nFormal Charge\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nComplexity\n\nProperty Value\n\n434\n\nReference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nIsotope Atom Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nDefined Atom Stereocenter Count\n\n\n                    Context: \n                    This chunk is part of the \"Chemical and Physical Properties\" section for temazepam, detailing computed molecular properties such as rotatable bond count, exact mass, monoisotopic mass, topological polar surface area, heavy atom count, formal charge, molecular complexity, and other structural descriptors, each with their method or software reference. This information helps define temazepam's physicochemical characterization within its full PubChem compound profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_9", "document_index": 65, "latency_s": 34.5709174000076, "prompt_toks": 17577, "completion_toks": 78}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Reference\n\nComputed by Cactvs 3.4.8.18 (PubChem release 2021.10.14)\n\nProperty Name\n\nIsotope Atom Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nDefined Atom Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nUndefined Atom Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nDefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nUndefined Bond Stereocenter Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nCovalently-Bonded Unit Count\n\nProperty Value\n\nReference\n\nComputed by PubChem\n\nProperty Name\n\nCompound Is Canonicalized\n\nProperty Value\n\nYes\n\nReference\n\nComputed by PubChem (release 2021.10.14)\n\n3.2 Experimental Properties\n\n3.2.1 Physical Description\n\nSolid\n\n3.2.2 Melting Point\n\n119-121 °C\n\nPhysProp\n\n119 - 121 °C\n\n3.2.3 Solubility\n\n164 mg/L\n\n5.34e-02 g/L\n\n3.2.4 LogP\n\n2.19\n\nHANSCH,C ET AL. (1995)\n\n3.2.5 Collision Cross Section\n\n\n                    Context: \n                    This chunk is from the \"Chemical and Physical Properties\" section of the temazepam compound page, specifically listing computed and experimental physicochemical properties such as isotope and stereocenter counts, canonicalization status, physical state, melting point, solubility, logP, and collision cross section. It provides detailed substance characterization useful for identification, laboratory handling, and research applications.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_10", "document_index": 65, "latency_s": 35.055924100015545, "prompt_toks": 17646, "completion_toks": 90}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Solid\n\n3.2.2 Melting Point\n\n119-121 °C\n\nPhysProp\n\n119 - 121 °C\n\n3.2.3 Solubility\n\n164 mg/L\n\n5.34e-02 g/L\n\n3.2.4 LogP\n\n2.19\n\nHANSCH,C ET AL. (1995)\n\n3.2.5 Collision Cross Section\n\n166.1 Å² [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]\n\nhttps://www.sciencedirect.com/science/article/pii/S0021967318301894\n\n3.2.6 Kovats Retention Index\n\nStandard non-polar\n\n2600 , 2554 , 2554 , 2575 , 2589 , 2589 , 2613 , 2588 , 2590 , 2595\n\nSemi-standard non-polar\n\n2691.5 , 2597.9 , 2595.7 , 2595.5 , 2597.1 , 2613 , 2603.7\n\n3.3 Chemical Classes\n\nPharmaceutical\n\n3.3.1 Drugs\n\nPharmaceuticals -> Hypnotic\n\nS56 | UOATARGPHARMA | Target Pharmaceutical/Drug List from University of Athens | DOI:10.5281/zenodo.3248837\n\nPharmaceuticals\n\nS10 | SWISSPHARMA | Pharmaceutical List with Consumption Data | DOI:10.5281/zenodo.2623484\n\nPharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds\n\n\n                    Context: \n                    This chunk appears in the \"Chemical and Physical Properties\" section of the Temazepam compound page. It provides key experimental data on temazepam's physical description (solid), melting point, solubility, logP value, collision cross section, and retention indices. These details follow computed chemical properties and precede the section on chemical classification and pharmaceutical categorization, helping researchers quickly access experimentally determined physical and chemical parameters of temazepam.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_11", "document_index": 65, "latency_s": 34.88185009997687, "prompt_toks": 17598, "completion_toks": 112}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Pharmaceuticals\n\nS10 | SWISSPHARMA | Pharmaceutical List with Consumption Data | DOI:10.5281/zenodo.2623484\n\nPharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds\n\nS58 | PSYCHOCANNAB | Synthetic Cannabinoids and Psychoactive Compounds | DOI:10.5281/zenodo.3247723\n\n3.3.1.1 Human Drugs\n\nBreast Feeding; Lactation; Milk, Human; Hypnotics and Sedatives; Anti-Anxiety Agents; Benzodiazepines\n\nHuman drug -> Discontinued\n\nHuman drug -> Prescription\n\nHuman drug -> Prescription; Discontinued; Active ingredient (TEMAZEPAM)\n\nPharmaceuticals\n\nS72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664\n\n4 Spectral Information\n\n4.1 Mass Spectrometry\n\n4.1.1 GC-MS\n\n1 of 7\n\nView All\n\nNIST Number\n\n248966\n\nLibrary\n\nMain library\n\nTotal Peaks\n\n189\n\nm/z Top Peak\n\n271\n\nm/z 2nd Highest\n\n273\n\nm/z 3rd Highest\n\n300\n\nThumbnail\n\nThumbnail\n\n2 of 7\n\nView All\n\nNIST Number\n\n125811\n\nLibrary\n\nReplicate library\n\nTotal Peaks\n\n171\n\nm/z Top Peak\n\n271\n\n\n                    Context: \n                    This section appears within the broader classification and characterization of temazepam, detailing its categorization as a pharmaceutical—specifically as a hypnotic, sedative, anti-anxiety agent, and benzodiazepine—along with regulatory and usage status (e.g., discontinued, prescription). It transitions into the analytical characterization of temazepam, introducing the spectral information section, including mass spectrometry data (GC-MS), key instrument identifiers (such as NIST numbers), and notable spectral peaks, supporting compound verification and identification in research and pharmaceutical contexts.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_12", "document_index": 65, "latency_s": 34.596897400013404, "prompt_toks": 17697, "completion_toks": 94}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    189\n\nm/z Top Peak\n\n271\n\nm/z 2nd Highest\n\n273\n\nm/z 3rd Highest\n\n300\n\nThumbnail\n\nThumbnail\n\n2 of 7\n\nView All\n\nNIST Number\n\n125811\n\nLibrary\n\nReplicate library\n\nTotal Peaks\n\n171\n\nm/z Top Peak\n\n271\n\nm/z 2nd Highest\n\n273\n\nm/z 3rd Highest\n\n77\n\nThumbnail\n\nThumbnail\n\n4.1.2 MS-MS\n\n1 of 7\n\nView All\n\nSpectra ID\n\n2226367\n\nIonization Mode\n\nPositive\n\nSPLASH\n\nsplash10-0a4i-0092000000-6a05dc5e5e75afdcbb8e\n\nTop 5 Peaks\n\n255.0683 100\n\n301.0739 41.26\n\n283.0633 21.14\n\n193.0886 4.52\n\n228.0573 3.41\n\nThumbnail\n\nThumbnail\n\n2 of 7\n\nView All\n\nSpectra ID\n\n2227164\n\nIonization Mode\n\nPositive\n\nSPLASH\n\nsplash10-0a4i-0390000000-d827d877da314f89978b\n\nTop 5 Peaks\n\n255.0679 100\n\n257.065 28.72\n\n193.0875 24.33\n\n256.071 15.63\n\n177.0202 12.52\n\nThumbnail\n\nThumbnail\n\n4.1.3 LC-MS\n\n1 of 45\n\nView All\n\nAccession ID\n\nMSBNK-Athens_Univ-AU155701\n\nAuthors\n\nNikiforos Alygizakis, Nikolaos Thomaidis, University of Athens\n\nInstrument\n\nBruker maXis Impact\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\n\n                    Context: \n                    This chunk is from the \"Spectral Information\" section of the document, specifically detailing mass spectrometry (MS) data for temazepam. It presents results from various MS methods including GC-MS, MS-MS, and LC-MS, listing the number of total peaks, major m/z values, spectral IDs, ionization modes, and key peak abundances. This data aids in the chemical identification and analytical confirmation of temazepam in laboratory settings.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_13", "document_index": 65, "latency_s": 34.95193239999935, "prompt_toks": 17661, "completion_toks": 102}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Authors\n\nNikiforos Alygizakis, Nikolaos Thomaidis, University of Athens\n\nInstrument\n\nBruker maXis Impact\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\nCollision Energy\n\n10 eV\n\nFragmentation Mode\n\nCID\n\nColumn Name\n\nAcclaim RSLC C18 2.2um, 2.1x100mm, Thermo\n\nRetention Time\n\n8.4 min\n\nPrecursor m/z\n\n301.0738\n\nPrecursor Adduct\n\n[M+H]+\n\nTop 5 Peaks\n\n301.0738 999\n\n303.0714 256\n\n302.0765 182\n\n283.0628 151\n\n255.0679 44\n\nSPLASH\n\nsplash10-0udi-0019000000-f9c9fe92391b593143eb\n\nThumbnail\n\nThumbnail\n\nLicense\n\nCC BY-SA\n\n2 of 45\n\nView All\n\nAccession ID\n\nMSBNK-Athens_Univ-AU155702\n\nAuthors\n\nNikiforos Alygizakis, Nikolaos Thomaidis, University of Athens\n\nInstrument\n\nBruker maXis Impact\n\nInstrument Type\n\nLC-ESI-QTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nIonization\n\nESI\n\nCollision Energy\n\n20 eV\n\nFragmentation Mode\n\nCID\n\nColumn Name\n\nAcclaim RSLC C18 2.2um, 2.1x100mm, Thermo\n\nRetention Time\n\n8.4 min\n\nPrecursor m/z\n\n301.0738\n\nPrecursor Adduct\n\n[M+H]+\n\n\n                    Context: \n                    This chunk appears in the \"4 Spectral Information\" section of the Temazepam PubChem page, specifically under \"4.1 Mass Spectrometry\" -> \"4.1.3 LC-MS.\" It details LC-ESI-QTOF MS/MS experimental data for Temazepam, including instrument specifications, chromatographic conditions, fragmentation parameters, retention times, precursor ion information, and key spectral peaks, as part of a broader set of mass spectrometry reference spectra for this compound.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_14", "document_index": 65, "latency_s": 35.30362099999911, "prompt_toks": 17686, "completion_toks": 79}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Ionization\n\nESI\n\nCollision Energy\n\n20 eV\n\nFragmentation Mode\n\nCID\n\nColumn Name\n\nAcclaim RSLC C18 2.2um, 2.1x100mm, Thermo\n\nRetention Time\n\n8.4 min\n\nPrecursor m/z\n\n301.0738\n\nPrecursor Adduct\n\n[M+H]+\n\nTop 5 Peaks\n\n255.0685 999\n\n283.0632 341\n\n257.0653 280\n\n301.0738 164\n\n256.0713 157\n\nSPLASH\n\nsplash10-0a4i-0091000000-b26b004678460e39d9db\n\nThumbnail\n\nThumbnail\n\nLicense\n\nCC BY-SA\n\n4.1.4 MALDI\n\nAccession ID\n\nMSBNK-JEOL_Ltd-JEL00042\n\nAuthors\n\nJEOL Ltd.\n\nInstrument\n\nJMS-S3000\n\nInstrument Type\n\nMALDI-TOFTOF\n\nMS Level\n\nMS2\n\nIonization Mode\n\nPOSITIVE\n\nPrecursor m/z\n\n301.07383\n\nTop 5 Peaks\n\n282.99366 999\n\n255.06663 263\n\n51.12347 247\n\n77.13624 219\n\n228.10281 208\n\nSPLASH\n\nsplash10-003r-9570000000-d80dee671a86e7bf5ce6\n\nThumbnail\n\nThumbnail\n\nLicense\n\nCC BY-NC-SA\n\n4.1.5 Other MS\n\nMoNA ID\n\nJEL00042\n\nMS Category\n\nExperimental\n\nMS Type\n\nOther\n\nMS Level\n\nMS2\n\nPrecursor Type\n\n[M+H]+\n\nPrecursor m/z\n\n301.07383\n\nInstrument\n\nJMS-S3000\n\nInstrument Type\n\nMALDI-TOFTOF\n\nIonization Mode\n\npositive\n\nTop 5 Peaks\n\n\n                    Context: \n                    This chunk is from the section presenting experimental mass spectrometry (MS) data for temazepam, specifically detailing LC-MS/MS and MALDI-TOFTOF MS/MS spectra. It lists instrument parameters, precursor ions, major fragment peaks, SPLASH identifiers, and licensing information, as part of comprehensive spectral characterization in the broader context of the compound’s analytical and structural data.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_15", "document_index": 65, "latency_s": 35.12942720000865, "prompt_toks": 17626, "completion_toks": 89}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Experimental\n\nMS Type\n\nOther\n\nMS Level\n\nMS2\n\nPrecursor Type\n\n[M+H]+\n\nPrecursor m/z\n\n301.07383\n\nInstrument\n\nJMS-S3000\n\nInstrument Type\n\nMALDI-TOFTOF\n\nIonization Mode\n\npositive\n\nTop 5 Peaks\n\n282.99366 100\n\n255.06663 26.38\n\n51.12347 24.76\n\n77.13624 21.93\n\n228.10281 20.79\n\nSPLASH\n\nsplash10-003r-9570000000-d80dee671a86e7bf5ce6\n\nThumbnail\n\nThumbnail\n\nLicense\n\nCC BY-NC-SA\n\n4.2 IR Spectra\n\n4.2.1 FTIR Spectra\n\nInstrument Name\n\nBio-Rad FTS\n\nTechnique\n\nKBr1 0.45mg\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nAlltech Associates, Inc., Grace Davison Discovery Sciences\n\nCatalog Number\n\n01383\n\nLot Number\n\n080697A\n\nCopyright\n\nCopyright © 2012-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.2.2 ATR-IR Spectra\n\nInstrument Name\n\nBio-Rad FTS\n\nTechnique\n\nATR-Neat (DuraSamplIR II) CIV\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nAlltech Associates, Inc., Grace Davison Discovery Sciences\n\nCatalog Number\n\n01383\n\nLot Number\n\n080697A\n\n\n                    Context: \n                    This chunk is from the analytical spectral data section of the temazepam compound page, specifically providing details on experimental mass spectrometry (MS) results using MALDI-TOFTOF instrumentation, including main detected peaks, instrument settings, and licensing. It is immediately followed by data on IR spectra (FTIR and ATR-IR) for temazepam, which are part of the compound's comprehensive physical and chemical characterization within the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_16", "document_index": 65, "latency_s": 34.18219400002272, "prompt_toks": 17530, "completion_toks": 55}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Source of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nAlltech Associates, Inc., Grace Davison Discovery Sciences\n\nCatalog Number\n\n01383\n\nLot Number\n\n080697A\n\nCopyright\n\nCopyright © 2009-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n4.3 Raman Spectra\n\nTechnique\n\nFT-Raman\n\nSource of Spectrum\n\nForensic Spectral Research\n\nSource of Sample\n\nAlltech Associates, Inc., Grace Davison Discovery Sciences\n\nCatalog Number\n\n01383\n\nLot Number\n\n080697A\n\nCopyright\n\nCopyright © 2012-2025 John Wiley & Sons, Inc. All Rights Reserved.\n\nThumbnail\n\nThumbnail\n\n5 Related Records\n\n5.1 Related Compounds with Annotation\n\nFollow these links to do a live 2D search or do a live 3D search for this compound, sorted by annotation score. This section is deprecated (see here for details), but these live search links provide equivalent functionality to the table that was previously shown here.\n\n5.2 Related Compounds\n\nSame Connectivity Count\n\n11\n\nSame Stereo Count\n\n\n                    Context: \n                    This chunk is part of the spectral information section of the temazepam compound page, specifically providing details about the sources, catalog, and copyright information for forensic FT-Raman spectra, and is immediately followed by the start of the related records section listing related compounds and annotation tools.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_17", "document_index": 65, "latency_s": 35.176514500024496, "prompt_toks": 17505, "completion_toks": 83}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    5.2 Related Compounds\n\nSame Connectivity Count\n\n11\n\nSame Stereo Count\n\nSame Isotope Count\n\nSame Parent, Connectivity Count\n\n19\n\nSame Parent, Stereo Count\n\n17\n\nSame Parent, Isotope Count\n\n11\n\nSame Parent, Exact Count\n\nMixtures, Components, and Neutralized Forms Count\n\n41\n\nSimilar Compounds (2D)\n\nView in PubChem Search\n\nSimilar Conformers (3D)\n\nView in PubChem Search\n\n5.3 Substances\n\n5.3.1 PubChem Reference Collection SID\n\n483926387\n\n5.3.2 Related Substances\n\nAll Count\n\n177\n\nSame Count\n\n113\n\nMixture Count\n\n64\n\n5.3.3 Substances by Category\n\n5.4 Entrez Crosslinks\n\nPubMed Count\n\n365\n\nTaxonomy Count\n\nOMIM Count\n\nGene Count\n\n18\n\n5.5 NCBI LinkOut\n\n6 Chemical Vendors\n\n7 Drug and Medication Information\n\n7.1 Drug Indication\n\n\n                    Context: \n                    This section provides data on chemical relationships and external references for temazepam, listing related compounds by structural similarity, associated substances, substance counts, and cross-links to external biomedical databases such as PubMed and OMIM. It serves as a bridge between temazepam’s core chemical/property information and drug/medication details, facilitating exploration of structurally or functionally related entities and access to linked scientific literature and databases.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_18", "document_index": 65, "latency_s": 34.61585139998351, "prompt_toks": 17480, "completion_toks": 105}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    7 Drug and Medication Information\n\n7.1 Drug Indication\n\nTemazepam is specifically indicated only for the short-term management of insomnia,. Furthermore, such management is generally predominantly associated with the symptomatic relief of transient and short-term insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings and/or early morning awakenings. In particular, the official prescribing information for temazepam typically specifies that the instructions issued for dispensed prescriptions of the medication should indicate specifically that patients are only expected to use the therapy for short periods of time - usually 7-10 days in general. Subsequently, treatment with temazepam should usually not exceed 7 to 10 consecutive days and nor should it be prescribed in quantities exceeding a one-month supply. Some regional prescribing information also notes that temazepam may be used for premedication prior to minor surgery or other related procedures.\n\n\n                    Context: \n                    Section 7 provides clinical drug and medication information for temazepam, focusing here on its official medical indications. This chunk details temazepam's use as a short-term treatment for insomnia, specifies recommended duration and dosing limitations, and notes possible use as premedication before minor procedures. It is situated among sections covering chemical properties, safety, pharmacology, adverse effects, and regulatory status, supplying prescribers with essential therapeutic usage guidance within the wider context of temazepam’s chemical, regulatory, and safety profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_19", "document_index": 65, "latency_s": 34.056437999999616, "prompt_toks": 17573, "completion_toks": 75}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    FDA Label\n\n7.2 LiverTox Summary\n\nTemazepam is an orally available benzodiazepine used in the therapy of insomnia. As with most benzodiazepines, temazepam has not been associated with serum aminotransferase or alkaline phosphatase elevations during therapy, and clinically apparent liver injury from temazepam has not been reported and must be very rare, if it occurs at all.\n\n7.3 Drug Classes\n\nBreast Feeding; Lactation; Milk, Human; Hypnotics and Sedatives; Anti-Anxiety Agents; Benzodiazepines\n\nSedatives and Hypnotics\n\n7.4 FDA Medication Guides\n\nDrug\n\nActive Ingredient\n\nForm;Route\n\nCompany\n\nDate\n\nDrug\n\nRESTORIL\n\nActive Ingredient\n\nTEMAZEPAM\n\nForm;Route\n\nCAPSULE;ORAL\n\nCompany\n\nSPECGX LLC\n\nDate\n\n1/13/23\n\n7.5 FDA Approved Drugs\n\n7.6 FDA Orange Book\n\n7.7 FDA National Drug Code Directory\n\n7.8 Drug Labels\n\nDrug and label\n\nActive ingredient and drug\n\n7.9 Clinical Trials\n\n7.9.1 ClinicalTrials.gov\n\n7.9.2 EU Clinical Trials Register\n\n7.10 DEA Drug and Chemical Information\n\n\n                    Context: \n                    This section is part of the drug and medication information for temazepam, following the main drug indication details. It provides regulatory, safety, and classification data, including a LiverTox safety summary, pharmacological classes, FDA medication guides such as brand and manufacturer, and links to FDA drug approval and coding resources, as well as references to clinical trial data and DEA scheduling.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_20", "document_index": 65, "latency_s": 34.757320000004256, "prompt_toks": 17493, "completion_toks": 94}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    7.8 Drug Labels\n\nDrug and label\n\nActive ingredient and drug\n\n7.9 Clinical Trials\n\n7.9.1 ClinicalTrials.gov\n\n7.9.2 EU Clinical Trials Register\n\n7.10 DEA Drug and Chemical Information\n\n7.10.1 DEA Controlled Substances\n\n1 of 3\n\nSubstance\n\nTemazepam\n\nDEA Controlled Substances Code Number\n\n2925\n\nControlled Substances Act Schedule\n\nSchedule IV - Substances in the DEA Schedule IV have a low potential for abuse relative to substances in Schedule III.\n\nClass\n\nDepressants\n\n2 of 3\n\nNon-Proprietary Name\n\nTEMAZEPAM\n\nDEA Substances Act Schedule\n\nSchedule IV\n\n3 of 3\n\nNon-Proprietary Name\n\nTEMAZEPAM CIV\n\nDEA Substances Act Schedule\n\nSchedule IV\n\n8 Pharmacology and Biochemistry\n\n8.1 Pharmacodynamics\n\n\n                    Context: \n                    This chunk appears within the \"Drug and Medication Information\" section of the document, directly following details about drug indications, drug classes, and FDA medication guides for temazepam. It specifically covers official drug labels, references to clinical trials, and, most notably, the controlled substance status of temazepam according to the DEA—including its Schedule IV classification and depressant class. This precedes a more in-depth exploration of temazepam’s pharmacology and biochemistry.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_21", "document_index": 65, "latency_s": 34.67616099998122, "prompt_toks": 17514, "completion_toks": 76}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Temazepam is a benzodiazepine used as a hypnotic agent in the management of insomnia. Temazepam produces CNS depression at limbic, thalamic, and hypothalamic levels of the CNS. Temazepam increases the affinity of the neurotransmitter gamma-aminobutyric acid (GABA) for GABA receptors by binding to benzodiazepine receptors. Results are sedation, hypnosis, skeletal muscle relaxation, anticonvulsant activity, and anxiolytic action. In sleep laboratory studies, the effect of temazepam was compared to placebo during a two week period. The studies demonstrated a linear dose-response improvement in total sleep time and sleep latency with substantial drug-placebo differences apparent for total sleep time and for sleep latency at higher doses of temazepam. Regardless, REM sleep was ultimately unchanged but slow wave sleep was decreased. Moreover, a transient syndrome, known as \"rebound insomnia\", wherein the symptoms that led to treatment with temazepam in the first place recur in an enhanced\n\n\n                    Context: \n                    This passage appears in the \"Pharmacology and Biochemistry\" section of the document, specifically under \"Pharmacodynamics.\" It provides an overview of temazepam's mechanism of action as a benzodiazepine hypnotic, its effects on the central nervous system, clinical sleep study findings, and phenomena such as rebound insomnia related to its pharmacologic use in managing insomnia.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_22", "document_index": 65, "latency_s": 34.77427719999105, "prompt_toks": 17492, "completion_toks": 94}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    but slow wave sleep was decreased. Moreover, a transient syndrome, known as \"rebound insomnia\", wherein the symptoms that led to treatment with temazepam in the first place recur in an enhanced form, may happen on withdrawal of temazepam treatment. The possibility of this occurrence is in part why long term use of temazepam is not recommended due to worries over tolerance and dependence wherein patients' bodies become physiologically accustomed to the regular presence and pharmacological effect of higher and higher doses of the benzodiazepine used. The duration of hypnotic effect and the profile of unwanted adverse effects may be influenced by the distribution and elimination half-lives of the administered temazepam and any active metabolites that may be formed. When such half-lives are long, the drug or its metabolite(s) may accumulate during periods of nightly administration and be associated with impairments of cognitive and motor performance during waking hours. Conversely, if\n\n\n                    Context: \n                    This passage appears within the pharmacodynamics section of the temazepam compound page, discussing the drug’s effects on sleep architecture, particularly its impact on slow wave sleep and the risk of rebound insomnia upon withdrawal. It explains why long-term use of temazepam is discouraged, addressing issues of tolerance, dependence, and how the pharmacokinetics (such as elimination half-life and metabolite accumulation) can influence both therapeutic and adverse effects, including next-day cognitive and motor impairment.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_23", "document_index": 65, "latency_s": 34.9711250999826, "prompt_toks": 17496, "completion_toks": 57}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    long, the drug or its metabolite(s) may accumulate during periods of nightly administration and be associated with impairments of cognitive and motor performance during waking hours. Conversely, if half-lives are short, the drug and metabolites would be cleared before the next dose is ingested, and carry-over effects related to sedation or CNS depression should be minimal or not present at all. However, during nightly use and for an extended period, pharmacodynamic tolerance or adaptation to some effects of benzodiazepine hypnotics may develop - which may also contribute to the possibility of 'rebound insomnia'. Consequently, if the drug has a very short elimination half-life, it is possible that a relative deficiency (for example, in relation to benzodiazepine GABA(a) receptor sites) may occur at some point in the interval between each night's use. This sequence of events may account for certain clinical findings reported happening after several weeks of nightly use of rapidly\n\n\n                    Context: \n                    This passage is from the pharmacodynamics section of the temazepam compound page, discussing how the drug's half-life—whether long or short—affects drug accumulation, cognitive and motor side effects, risk of ‘rebound insomnia,’ and the development of pharmacodynamic tolerance with nightly use.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_24", "document_index": 65, "latency_s": 33.37749590000021, "prompt_toks": 17364, "completion_toks": 66}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    may occur at some point in the interval between each night's use. This sequence of events may account for certain clinical findings reported happening after several weeks of nightly use of rapidly eliminated benzodiazepine hypnotics, including increased wakefulness during the last third of the night and the appearance of increased daytime anxiety.\n\n\n                    Context: \n                    This chunk is part of the pharmacodynamics section describing the effects of temazepam, specifically discussing the consequences of nightly use of short half-life benzodiazepine hypnotics, such as the development of rebound insomnia, increased wakefulness in the latter part of the night, and increased daytime anxiety following several weeks of continuous use.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_25", "document_index": 65, "latency_s": 35.00924399998621, "prompt_toks": 17522, "completion_toks": 82}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    8.2 MeSH Pharmacological Classification\n\nGABA Modulators\n\nSubstances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)\n\nHypnotics and Sedatives\n\nDrugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)\n\nAnti-Anxiety Agents\n\n\n                    Context: \n                    This section provides the MeSH (Medical Subject Headings) pharmacological classification of temazepam, detailing its roles as a GABA modulator, hypnotic/sedative, and anti-anxiety agent. It appears within the broader pharmacology and biochemistry segment, supporting the document's coverage of temazepam’s mechanism of action, drug classes, and therapeutic effects as a benzodiazepine.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_26", "document_index": 65, "latency_s": 34.74788720000652, "prompt_toks": 17572, "completion_toks": 104}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Hypnotics and Sedatives\n\nDrugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)\n\nAnti-Anxiety Agents\n\nAgents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)\n\n8.3 FDA Pharmacological Classification\n\n1 of 3\n\nFDA UNII\n\nCHB1QD2QSS\n\nActive Moiety\n\nTEMAZEPAM\n\nPharmacological Classes\n\nEstablished Pharmacologic Class [EPC] - Benzodiazepine\n\nPharmacological Classes\n\nChemical Structure [CS] - Benzodiazepines\n\nFDA Pharmacology Summary\n\nTemazepam is a Benzodiazepine.\n\n2 of 3\n\nNon-Proprietary Name\n\nTEMAZEPAM\n\nPharmacological Classes\n\nBenzodiazepine [EPC]; Benzodiazepines [CS]\n\n3 of 3\n\nNon-Proprietary Name\n\nTEMAZEPAM CIV\n\n\n                    Context: \n                    This section details the pharmacological classification of temazepam, listing its therapeutic classes such as \"Hypnotics and Sedatives\" and \"Anti-Anxiety Agents,\" and providing the FDA's official drug class designations. It situates temazepam within broader drug categories and presents regulatory identifiers used for classification in clinical and regulatory contexts. This content appears within the broader pharmacology and biochemistry portion of the document, following descriptions of temazepam's mechanisms of action and preceding absorption, metabolism, and usage information.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_27", "document_index": 65, "latency_s": 37.225884699990274, "prompt_toks": 17464, "completion_toks": 81}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Temazepam is a Benzodiazepine.\n\n2 of 3\n\nNon-Proprietary Name\n\nTEMAZEPAM\n\nPharmacological Classes\n\nBenzodiazepine [EPC]; Benzodiazepines [CS]\n\n3 of 3\n\nNon-Proprietary Name\n\nTEMAZEPAM CIV\n\nPharmacological Classes\n\nBenzodiazepines [CS]; Benzodiazepine [EPC]\n\n8.4 ATC Code\n\nN - Nervous system\n\nN05 - Psycholeptics\n\nN05C - Hypnotics and sedatives\n\nN05CD - Benzodiazepine derivatives\n\nN05CD07 - Temazepam\n\n8.5 Absorption, Distribution and Excretion\n\nAbsorption\n\n\n                    Context: \n                    This section details the pharmacological classification of temazepam, listing its non-proprietary names, pharmacological classes (as various forms of benzodiazepine), and providing its ATC (Anatomical Therapeutic Chemical) code, followed by information on its absorption, distribution, and excretion. It connects the drug’s regulatory and scientific categorization with subsequent in-depth pharmacokinetic data.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_28", "document_index": 65, "latency_s": 32.98000119999051, "prompt_toks": 17549, "completion_toks": 82}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    8.4 ATC Code\n\nN - Nervous system\n\nN05 - Psycholeptics\n\nN05C - Hypnotics and sedatives\n\nN05CD - Benzodiazepine derivatives\n\nN05CD07 - Temazepam\n\n8.5 Absorption, Distribution and Excretion\n\nAbsorption\n\nStudies demonstrate that between 90 to 100% of an orally administered temazepam dose is absorbed, making the medication very well absorbed. The oral administration of 15 to 45 mg temazepam resulted in rapid absorption with significant blood levels achieved in 30 minutes and peak levels at 2-3 hours. In particular, direct studies following the oral ingestion of 30 mg of temazepam revealed measurable plasma concentrations were obtained 10-20 minutes after dosing with peak plasma levels ranging between 666-982 ng/mL (with a mean of 865 ng/mL) presenting approximately 1.2-1.6 hours (with a mean of 1.5 hours) after the dosing. Finally, a dose-proportional relationship was established for the area under the plasma concentration/time curve over the 15 to 30 mg dose range.\n\nRoute of Elimination\n\n\n                    Context: \n                    This section is part of the Pharmacology and Biochemistry content detailing temazepam's official drug classification within the ATC (Anatomical Therapeutic Chemical) system and providing specific information on its absorption, distribution, and elimination from the body, including pharmacokinetic data such as bioavailability and time to peak plasma levels. It follows the mechanism of action and precedes further details on metabolism and elimination pathways.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_29", "document_index": 65, "latency_s": 34.72213549999287, "prompt_toks": 17480, "completion_toks": 113}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Route of Elimination\n\nFollowing a single dose, 80-90% of the dose appears in the urine, predominantly as the O-conjugate metabolite, and 3-13% of the dose appears in the faeces. Less than 2% of the dose is excreted unchanged or as N-desmethyltemazepam in the urine.\n\nVolume of Distribution\n\nThe volume of distribution documented for temazepam is 1.3-1.5 L/kg body weight - and in particular, 43-68 L/kg for the unbound fraction.\n\nClearance\n\nStudies regarding the clearance of temazepam have recorded the values of 1.03 ml/min/kg and 31 ml/min/kg for the clearance of total temazepam and the clearance of unbound temazepam, respectively.\n\n8.6 Metabolism / Metabolites\n\n\n                    Context: \n                    This chunk appears in the pharmacokinetics section of the document, detailing key aspects of temazepam’s absorption, distribution, metabolism, and excretion (ADME). Specifically, it provides data on how temazepam is eliminated from the body (primarily via urine as metabolites, with minor fecal excretion and minimal unchanged drug), its volume of distribution, and clearance rates. This information is presented immediately before the section on metabolic pathways and metabolites, helping clinicians and researchers understand temazepam’s biodisposition and inform dosing and safety considerations.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_30", "document_index": 65, "latency_s": 33.73687219998101, "prompt_toks": 17517, "completion_toks": 140}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    8.6 Metabolism / Metabolites\n\nFirst-pass metabolism of temazepam is minimal at approximately 5-8% of an administered dose. Nevertheless, temazepam is principally metabolized in the liver where most of the unchanged drug is directly conjugated to glucuronide and excreted in the urine. In particular, the primary metabolite present in the blood is the O-conjugate of temazepam. Less than 5% of the drug is demethylated to oxazepam and subsequently eliminated as the glucuronide. Regardless, the glucuronides of temazepam have no demonstrable CNS activity and it is believed that no active metabolites are formed in general. Since temazepam mainly undergoes Phase II conjugation reactions, it is proposed that it is devoid of CYP450 interactions.\n\nTemazepam is a known human metabolite of diazepam.\n\nS73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560\n\n\n                    Context: \n                    Section 8.6 \"Metabolism / Metabolites\" explains how temazepam is metabolized in the body, emphasizing minimal first-pass metabolism, primary hepatic conjugation to glucuronides, and excretion in the urine. It clarifies that temazepam has no significant active metabolites, undergoes mainly Phase II metabolism (with limited CYP450 involvement), and notes its status as a human metabolite of diazepam. This section fits within the broader pharmacology and biochemistry discussion (Section 8), which covers pharmacodynamics, mechanism of action, pharmacokinetics, and related biotransformation details relevant to temazepam's clinical and toxicological profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_31", "document_index": 65, "latency_s": 34.47223949999898, "prompt_toks": 17472, "completion_toks": 102}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Temazepam is a known human metabolite of diazepam.\n\nS73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560\n\nHepatic. Temazepam is completely metabolized through conjugation prior to excretion. The major metabolite is the O-conjugate of temazepam (90%). Route of Elimination: Temazepam was completely metabolized through conjugation prior to excretion; 80% to 90% of the dose appeared in the urine. Half Life: 10-20 hours\n\n8.7 Biological Half-Life\n\nThe terminal half-life determined for temazepam is recorded as being between 3.5-18 hours, with a mean of 9 hours.\n\n8.8 Mechanism of Action\n\n\n                    Context: \n                    This section is part of the pharmacokinetics and metabolism discussion for temazepam, describing its transformation in the body, elimination pathways, and biological half-life. It explains that temazepam is a metabolite of diazepam, is primarily metabolized in the liver via conjugation (mainly forming an O-conjugate excreted in urine), and provides details about its half-life, serving as background for understanding its duration of action and metabolic fate prior to the explanation of its mechanism of action.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_32", "document_index": 65, "latency_s": 38.654649200005224, "prompt_toks": 17501, "completion_toks": 64}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Gamma-Aminobutyric acid (GABA) is considered the principal inhibitory neurotransmitter in the human body. When GABA binds to GABA(a) receptors found in neuron synapses, chloride ions are conducted across neuron cell membranes via an ion channel in the receptors. With enough chloride ions conducted, the local, associated neuron membrane potentials are hyperpolarized - making it more difficult or less likely for action potentials to fire, ultimately resulting in less excitation of the neurons. Subsequently, benzodiazepines like temazepam can bind to benzodiazepine receptors that are components of various varieties of GABA(a) receptors. This binding acts to enhance the effects of GABA by increasing GABA affinity for the GABA(a) receptor, which ultimately enhances GABA ligand binding at the receptors. This enhanced ligand binding of the inhibitory neurotransmitter GABA to the receptors increases the aforementioned chloride ion conduction (perhaps reportedly via an increase in the\n\n\n                    Context: \n                    This passage explains the mechanism of action of temazepam, detailing how it exerts its effects as a benzodiazepine by enhancing GABAergic neurotransmission through increased affinity and binding at GABA(a) receptors, leading to neuronal inhibition; it appears in the pharmacology and biochemistry section following pharmacodynamics.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_33", "document_index": 65, "latency_s": 30.22181739998632, "prompt_toks": 17423, "completion_toks": 88}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    at the receptors. This enhanced ligand binding of the inhibitory neurotransmitter GABA to the receptors increases the aforementioned chloride ion conduction (perhaps reportedly via an increase in the frequency of the chloride channel opening), resulting in a hyperpolarized cell membrane that prevents further excitation of the associated neuron cells. Combined with the notion that such benzodiazepine receptor associated GABA(a) receptors exist both peripherally and in the CNS, this activity consequently facilitates various effects like sedation, hypnosis, skeletal muscle relaxation, anticonvulsant activity, and anxiolytic action.\n\n\n                    Context: \n                    This passage is from the section describing the mechanism of action of temazepam. It explains how temazepam, a benzodiazepine, enhances the binding of GABA to GABA(a) receptors, increasing chloride ion flow and leading to reduced neuronal excitation. This mechanism underlies temazepam's effects such as sedation, hypnosis, muscle relaxation, anticonvulsant, and anxiolytic activity.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_34", "document_index": 65, "latency_s": 34.386497500003316, "prompt_toks": 17576, "completion_toks": 68}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    8.9 Human Metabolite Information\n\n8.9.1 Tissue Locations\n\nKidney\n\nLiver\n\n8.9.2 Cellular Locations\n\nCytoplasm\n\nMembrane\n\n8.10 Transformations\n\n9 Use and Manufacturing\n\n9.1 Uses\n\nEPA CPDat Chemical and Product Categories\n\nThe Chemical and Products Database, a resource for exposure-relevant data on chemicals in consumer products, Scientific Data, volume 5, Article number: 180125 (2018), DOI:10.1038/sdata.2018.125\n\nUse (kg; approx.) in Germany (2009): >250\n\nUse (kg) in USA (2002): 2610\n\nConsumption (g per capita; approx.) in Germany (2009): 0.00305\n\nConsumption (g per capita) in the USA (2002): 0.00925\n\nCalculated removal (%): 23.4\n\nDOI:10.1021/acs.est.5b03332\n\nOfficially indicated for severe insomnia and other severe or disabling sleep disorders. For the short-term treatment of insomnia (generally 7-10 days).\n\n9.1.1 Use Classification\n\nHuman Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients\n\nPharmaceuticals\n\n\n                    Context: \n                    This section follows detailed pharmacology and metabolism data on temazepam, summarizing where temazepam and its metabolites are found in the body (kidney, liver, cytoplasm, membrane), leading into information about its uses, consumption statistics, and regulatory classifications, marking the transition from biochemical properties to practical applications and regulatory context.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_35", "document_index": 65, "latency_s": 37.7510806999926, "prompt_toks": 17505, "completion_toks": 80}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    9.1.1 Use Classification\n\nHuman Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients\n\nPharmaceuticals\n\nS72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664\n\n10 Safety and Hazards\n\n10.1 Hazards Identification\n\n10.1.1 GHS Classification\n\nPictogram(s)\n\nIrritant\n\nSignal\n\nWarning\n\nGHS Hazard Statements\n\nH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]\n\nPrecautionary Statement Codes\n\nP264, P270, P301+P317, P330, and P501\n\n(The corresponding statement to each P-code can be found at the GHS Classification page.)\n\nECHA C&L Notifications Summary\n\nAggregated GHS information provided per 52 reports by companies from 7 notifications to the ECHA C&L Inventory.\n\n\n                    Context: \n                    This chunk appears at the transition between sections detailing the regulatory classification and official uses of temazepam (notably, its status as an FDA-approved drug ingredient) and the beginning of the safety and hazard information. It bridges the end of use/approval classifications with the introduction to chemical hazard identification, including GHS classification details, pictograms, signal words, and aggregated hazard data from regulatory sources.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_36", "document_index": 65, "latency_s": 32.25820769998245, "prompt_toks": 17515, "completion_toks": 102}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ECHA C&L Notifications Summary\n\nAggregated GHS information provided per 52 reports by companies from 7 notifications to the ECHA C&L Inventory.\n\nInformation may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.\n\n10.1.2 Hazard Classes and Categories\n\nAcute Tox. 4 (100%)\n\n10.2 Regulatory Information\n\nCalifornia Safe Cosmetics Program (CSCP) Reportable Ingredient\n\nHazard Traits - Developmental Toxicity\n\nAuthoritative List - Prop 65\n\nReport - regardless of intended function of ingredient in the product\n\nDEA Controlled Substances\n\nDEA schedule IV controlled substance\n\n21 CFR Sections 1308.11-1308.15 https://www.ecfr.gov/current/title-21/chapter-II/part-1308\n\nNew Zealand EPA Inventory of Chemical Status\n\n\n                    Context: \n                    This section appears within the broader Safety and Hazards portion of the Temazepam compound page, summarizing regulatory and hazard classification information. It details international safety notifications—such as GHS (Globally Harmonized System) acute toxicity, developmental toxicity per California’s Safe Cosmetics Program and Prop 65, DEA controlled substance scheduling, and status in regulatory inventories like New Zealand EPA—providing context on legal restrictions and toxicity-associated warnings relevant to temazepam’s handling, labeling, and use.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_37", "document_index": 65, "latency_s": 34.88628669999889, "prompt_toks": 17514, "completion_toks": 71}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    DEA schedule IV controlled substance\n\n21 CFR Sections 1308.11-1308.15 https://www.ecfr.gov/current/title-21/chapter-II/part-1308\n\nNew Zealand EPA Inventory of Chemical Status\n\nTemazepam: Does not have an individual approval but may be used under an appropriate group standard\n\n10.3 Other Safety Information\n\nChemical Assessment\n\nIMAP assessments - 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-: Environment tier I assessment\n\nIMAP assessments - 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-: Human health tier I assessment\n\n11 Toxicity\n\n11.1 Toxicological Information\n\n11.1.1 Toxicity Summary\n\nSigns and Symptoms of Overdose\n\n\n                    Context: \n                    This chunk appears in the Safety and Hazards section of the Temazepam compound entry. It follows regulatory and classification details, including DEA scheduling and international regulatory status, and provides additional chemical safety assessments. Immediately after, the document transitions from safety information into the Toxicity section, beginning with a summary of toxicological effects, particularly signs and symptoms of overdose.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_38", "document_index": 65, "latency_s": 33.314575800002785, "prompt_toks": 17432, "completion_toks": 66}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11 Toxicity\n\n11.1 Toxicological Information\n\n11.1.1 Toxicity Summary\n\nSigns and Symptoms of Overdose\n\nDeaths from self-poisoning with temazepam alone or in combination with other substances were shown to be more common than with any other benzodiazepines except flurazepam, which had the highest mortality rate per million prescriptions. It has been claimed that disulfiram can hasten temazepam's toxicity by heightening the depression of the CNS. Acute overdosing on temazepam, like other benzodiazepines, manifests in sleepiness, confusion, and coma.\n\n\n                    Context: \n                    This section presents toxicological information on temazepam, specifically summarizing the signs and symptoms of overdose, comparative mortality risks, and factors that can exacerbate its central nervous system depressant effects. It is part of the larger document's comprehensive review of temazepam's chemical properties, pharmacology, safety, and clinical considerations.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_39", "document_index": 65, "latency_s": 35.09225049999077, "prompt_toks": 17490, "completion_toks": 78}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Moreover, it has been observed that overdoses of temazepam and zopiclone/zolpidem are more prone to fatalities compared to diazepam overdoses. Temazepam was found to be 10 times more hazardous than diazepam, whereas zopiclone, eszopiclone, zaleplon, and zolpidem (Z-drugs) were each just 9 times more toxic than diazepam. Temazepam has been associated with higher toxicity than other benzodiazepines in studies of intentional self-poisoning in a large national sample of veterans prescribed opioid analgesics. However, temazepam was linked to a lower overdose mortality rate than clonazepam. The oral LD50 of temazepam was 1963 mg/kg in mice, 1833 mg/kg in rats, and >2400 mg/kg in rabbits.\n\nManagement of Overdose\n\n\n                    Context: \n                    This passage appears in the toxicity section of the temazepam compound profile, specifically summarizing comparative overdose risk, acute toxicity data (including animal LD50 values), and the relative lethality of temazepam versus other benzodiazepines and Z-drugs in cases of overdose and intentional self-poisoning. It directly precedes content on the clinical management of temazepam overdose.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_40", "document_index": 65, "latency_s": 34.08754829998361, "prompt_toks": 17499, "completion_toks": 69}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Management of Overdose\n\nTemazepam overdose therapy involves supportive care, including airway, breathing, and circulatory examinations. Complex cases may require intensive care unit admission. The Poison Control Center can be contacted for assistance in complicated poisoning cases. The sedative effects of temazepam can be counteracted by flumazenil—a nonspecific competitive antagonist at the benzodiazepine receptor.\n\nBenzodiazepines bind nonspecifically to benzodiazepine receptors, which affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.\n\n\n                    Context: \n                    This section appears within the \"Toxicity\" part of the temazepam compound page and provides guidance on the clinical management of temazepam overdose, including supportive care measures and the use of flumazenil as an antidote. It also briefly explains the pharmacological action of benzodiazepines at the GABAA receptor.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_41", "document_index": 65, "latency_s": 39.29541230000905, "prompt_toks": 17391, "completion_toks": 107}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11.1.2 USGS Health-Based Screening Levels for Evaluating Water-Quality\n\nChemical\n\nTemazepam\n\nChemical Classes\n\nPharmaceutical\n\nReference\n\nSmith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP\n\n11.1.3 Hepatotoxicity\n\n\n                    Context: \n                    Section 11.1.2 provides information on environmental and health-based screening levels for temazepam as it relates to water-quality assessment, referencing standards for evaluating pharmaceutical contaminants. This is part of the broader Safety and Hazards and Toxicology section detailing the toxicological profile, adverse effects, overdose management, and organ-specific toxicity (with 11.1.3 directly following to address temazepam's potential for liver injury). The section is situated among detailed safety, environmental, regulatory, and health risk data for temazepam.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_42", "document_index": 65, "latency_s": 32.3118938000116, "prompt_toks": 17543, "completion_toks": 103}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Pharmaceutical\n\nReference\n\nSmith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP\n\n11.1.3 Hepatotoxicity\n\nTemazepam, like other benzodiazepines, is rarely associated with serum ALT elevations, and clinically apparent liver injury from temazepam is extremely rare, if it occurs at all. There have been no case reports of symptomatic, acute liver injury from temazepam. Isolated single cases of clinically apparent liver injury have been reported with other benzodiazepines including alprazolam, chlordiazepoxide, clonazepam, diazepam, flurazepam, lorazepam, and triazolam. The clinical pattern of acute liver injury from benzodiazepines is typically cholestatic and mild-to-moderate in severity with a latency of 1 to 6 months and rapid resolution with discontinuation. Fever and rash are uncommon as is autoantibody formation.\n\nLikelihood score: E (unlikely cause of clinically apparent liver injury).\n\n\n                    Context: \n                    This section appears under \"11 Toxicity\" in the temazepam compound profile, specifically addressing \"Hepatotoxicity.\" It summarizes the risk of liver injury associated with temazepam use, concluding that clinically apparent liver injury is extremely rare, with no reported cases for temazepam itself and only isolated cases for other benzodiazepines. This highlights the low likelihood of temazepam causing significant liver toxicity, contributing to the drug's overall safety profile discussed within the broader toxicity and adverse effects sections.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_43", "document_index": 65, "latency_s": 32.440551900013816, "prompt_toks": 17594, "completion_toks": 88}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Likelihood score: E (unlikely cause of clinically apparent liver injury).\n\n11.1.4 Drug Induced Liver Injury\n\nCompound\n\ntemazepam\n\nDILI Annotation\n\nAmbiguous DILI-concern\n\nSeverity Grade\n\nLabel Section\n\nWarnings and precautions\n\nReferences\n\nM Chen, V Vijay, Q Shi, Z Liu, H Fang, W Tong. FDA-Approved Drug Labeling for the Study of Drug-Induced Liver Injury, Drug Discovery Today, 16(15-16):697-703, 2011. PMID:21624500 DOI:10.1016/j.drudis.2011.05.007\n\nM Chen, A Suzuki, S Thakkar, K Yu, C Hu, W Tong. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today 2016, 21(4): 648-653. PMID:26948801 DOI:10.1016/j.drudis.2016.02.015\n\n11.1.5 Carcinogen Classification\n\n1 of 2\n\nIARC Carcinogenic Agent\n\nTemazepam\n\nIARC Carcinogenic Classes\n\nGroup 3: Not classifiable as to its carcinogenicity to humans\n\nIARC Monographs\n\nVolume 66: (1996) Some Pharmaceutical Drugs\n\n2 of 2\n\nCarcinogen Classification\n\n\n                    Context: \n                    This section presents the evaluation of temazepam's risk of drug-induced liver injury (DILI) and carcinogenicity, following the broader toxicity and safety data. It provides authoritative likelihood scores and annotations regarding liver injury risk, citing references on DILI classification systems and official drug labeling. It is immediately followed by carcinogen classification data from IARC, situating temazepam among substances not classifiable as to carcinogenicity in humans.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_44", "document_index": 65, "latency_s": 34.657398400013335, "prompt_toks": 17523, "completion_toks": 75}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Temazepam\n\nIARC Carcinogenic Classes\n\nGroup 3: Not classifiable as to its carcinogenicity to humans\n\nIARC Monographs\n\nVolume 66: (1996) Some Pharmaceutical Drugs\n\n2 of 2\n\nCarcinogen Classification\n\n3, not classifiable as to its carcinogenicity to humans. (L135)\n\n11.1.6 Health Effects\n\nThey cause slurred speech, disorientation and \"drunken\" behavior. They are physically and psychologically addictive.\n\n11.1.7 Effects During Pregnancy and Lactation\n\n◉ Summary of Use during Lactation\n\nBecause of the low levels of temazepam in breastmilk and its relatively short half-life, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants. Taking the bedtime dose after the infant's last feeding of the day may minimize the dose received by an older infant who is sleeping through the night. Monitor the infant for sedation, poor feeding and poor weight gain.\n\n◉ Effects in Breastfed Infants\n\n\n                    Context: \n                    This chunk is from the \"Toxicity\" section of the temazepam compound page, specifically addressing health effects, carcinogenicity classification (IARC Group 3: not classifiable as carcinogenic to humans), and safety considerations during pregnancy and lactation, including effects on breastfed infants. It provides summarized toxicological data relevant for health risk assessment and patient guidance.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_45", "document_index": 65, "latency_s": 34.666446500021266, "prompt_toks": 17452, "completion_toks": 89}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ◉ Effects in Breastfed Infants\n\nTen infants who were less than 15 days old were breastfed by mothers who had taken temazepam 10 or 20 mg (0.16 to 0.32 mg/kg) at bedtime once daily for at least 2 days. None of the infants had any observable adverse reactions.\n\nIn a telephone follow-up study, 124 mothers who took a benzodiazepine while nursing reported whether their infants had any signs of sedation. One mother took temazepam while breastfeeding and reported no sedation in her infant.\n\n◉ Effects on Lactation and Breastmilk\n\nRelevant published information was not found as of the revision date.\n\n◈ What is temazepam?\n\n\n                    Context: \n                    This section is part of the document's broader discussion on the safety, toxicity, and effects of temazepam, specifically addressing its use during pregnancy and lactation. It summarizes clinical observations of breastfed infants whose mothers took temazepam, noting the lack of adverse effects, and references available evidence on the drug’s impact on lactation, situating this information within the context of maternal and neonatal health considerations related to temazepam therapy.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_46", "document_index": 65, "latency_s": 35.64494170001126, "prompt_toks": 17495, "completion_toks": 84}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Temazepam is a medication that has been used to treat insomnia (having a hard time falling asleep or staying asleep). Temazepam is in a class of medications called benzodiazepines. It is sold under the brand name Restoril®.Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take this medication. If you take this medication regularly and then suddenly stop taking it (called “cold turkey”), you could have withdrawal symptoms. It is not known what effects, if any, withdrawal could have on a pregnancy.The product label for temazepam recommends people who are pregnant not use this medication during pregnancy. This is because there is concern based on the use of other medications like temazepam. Your healthcare providers can talk with you about the benefits of treating your condition and the\n\n\n                    Context: \n                    This chunk is part of the safety and toxicity section of the temazepam compound entry, focusing on guidance for use during pregnancy. It provides accessible information for patients considering changes to temazepam therapy if pregnant, highlighting potential withdrawal risks and emphasizing consultation with healthcare providers. This content supports broader discussions in the document regarding temazepam’s safety, regulatory status, adverse effects, and use in special populations such as pregnant individuals.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_47", "document_index": 65, "latency_s": 35.51841590000549, "prompt_toks": 17345, "completion_toks": 68}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    pregnancy. This is because there is concern based on the use of other medications like temazepam. Your healthcare providers can talk with you about the benefits of treating your condition and the risks of untreated illness during pregnancy.\n\n\n                    Context: \n                    This chunk appears in a section discussing the use of temazepam during pregnancy, specifically addressing concerns about its safety, potential effects on pregnancy outcomes, and the importance of consulting healthcare providers about the risks and benefits of using temazepam while pregnant, within the broader context of the drug’s toxicity, adverse effects, and guidance for special populations.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_48", "document_index": 65, "latency_s": 32.19255340000382, "prompt_toks": 17493, "completion_toks": 80}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ◈ I take temazepam. Can it make it harder for me to get pregnant?\n\nIt is not known if using temazepam could make it harder to get pregnant.\n\n◈ Does taking temazepam increase the chance of miscarriage?\n\nMiscarriage is common and can occur in any pregnancy for many different reasons. Studies have not been done to see if temazepam could increase the chance of miscarriage.\n\n◈ Does taking temazepam increase the chance of birth defects?\n\nEvery pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. Experimental animal studies did not find a higher chance for birth defects with exposure to temazepam. There was no increase in the chance for birth defects in one study involving 379 children exposed to temazepam during the first trimester of pregnancy.\n\n◈ Does taking temazepam in pregnancy increase the chance of other pregnancy-related problems?\n\n\n                    Context: \n                    This section addresses frequently asked questions about the reproductive and pregnancy safety of temazepam, specifically whether temazepam use affects fertility, the risk of miscarriage, birth defects, or other pregnancy-related complications. It forms part of the broader safety and toxicity information provided in the document, which discusses temazepam's effects during pregnancy and lactation, its side effects, overdose management, and regulatory status.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_49", "document_index": 65, "latency_s": 34.161129899992375, "prompt_toks": 17399, "completion_toks": 97}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ◈ Does taking temazepam in pregnancy increase the chance of other pregnancy-related problems?\n\nStudies have not been done to see if temazepam increases the chance for pregnancy-related problems such as preterm delivery (birth before week 37) or low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth).\n\n◈ I need to take temazepam throughout my entire pregnancy. Will it cause withdrawal symptoms in my baby after birth?\n\n\n                    Context: \n                    This section is part of the \"Effects During Pregnancy and Lactation\" subsection within the broader \"Toxicity\" and \"Safety and Hazards\" content. It addresses clinical questions about the risks of temazepam use during pregnancy, specifically concerning potential pregnancy-related complications such as preterm delivery or low birth weight, and the possibility of neonatal withdrawal symptoms. The information is based on available studies and safety data regarding temazepam exposure in pregnant individuals and its effects on infants.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_50", "document_index": 65, "latency_s": 34.46074830001453, "prompt_toks": 17470, "completion_toks": 72}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ◈ I need to take temazepam throughout my entire pregnancy. Will it cause withdrawal symptoms in my baby after birth?\n\nThe use of a benzodiazepine near the time of delivery could cause temporary symptoms in newborns soon after birth. These symptoms are sometimes referred to as withdrawal. Symptoms can include irritability, crying, sleep disturbances, tremors, jitteriness, trouble breathing, or muscle weakness. Not all babies exposed to a benzodiazepine will have symptoms. It is not known if the use of temazepam in pregnancy can cause symptoms in a newborn. It is important that your healthcare providers know you are taking temazepam so that if symptoms occur your baby can get the care that is best for them.\n\n◈ Can I take my benzodiazepine with diphenhydramine?\n\n\n                    Context: \n                    This section is part of the safety and toxicity information on temazepam, specifically addressing concerns about its use during pregnancy and the potential for neonatal withdrawal symptoms if temazepam is taken near delivery. It provides guidance for pregnant patients and discusses possible effects on newborns, situating this within frequently asked questions about temazepam's risks in pregnancy and breastfeeding.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_51", "document_index": 65, "latency_s": 34.68834339999012, "prompt_toks": 17476, "completion_toks": 79}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ◈ Can I take my benzodiazepine with diphenhydramine?\n\nA single human report and animal data have suggested that the combination of temazepam and diphenhydramine (Benadryl®) might increase the chance for stillbirth or for infant death shortly after birth. People taking temazepam should talk with their healthcare provider before taking diphenhydramine during their pregnancy. MotherToBaby has a fact sheet on diphenhydramine here: https://mothertobaby.org/fact-sheets/diphenhydramine-pregnancy/.\n\n◈ Does taking temazepam in pregnancy affect future behavior or learning for the child?\n\nStudies have not been done to see if temazepam can cause behavior or learning issues for the child.\n\n◈ Breastfeeding while taking temazepam:\n\n\n                    Context: \n                    This excerpt is from the section discussing the safety, risks, and considerations of temazepam use during pregnancy and breastfeeding. It covers potential drug interactions (specifically with diphenhydramine), possible effects on fetal and child development, and guidance for breastfeeding individuals taking temazepam. This information is part of the broader toxicity, adverse effects, and reproductive health guidance provided in the document.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_52", "document_index": 65, "latency_s": 34.33610809998936, "prompt_toks": 17433, "completion_toks": 85}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Studies have not been done to see if temazepam can cause behavior or learning issues for the child.\n\n◈ Breastfeeding while taking temazepam:\n\nTemazepam has not been well studied for use while breastfeeding. When given in a single intravenous (IV) dose, only small amounts of temazepam get into breast milk. No side effects were reported in 13 infants who were exposed to temazepam through breast milk. Be sure to talk to your healthcare provider about all your breastfeeding questions.\n\n◈ If a male takes temazepam, could it affect fertility (ability to get partner pregnant) or increase the chance of birth defects?\n\n\n                    Context: \n                    This section addresses the effects of temazepam on child development, breastfeeding, and male fertility, providing information about potential behavioral or learning issues in offspring, the transfer and safety of temazepam during lactation, and any risks related to paternal exposure. It is part of the broader safety and toxicity information on temazepam, including its effects during pregnancy, lactation, and fertility, based on clinical studies and expert recommendations.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_53", "document_index": 65, "latency_s": 34.36029189999681, "prompt_toks": 17450, "completion_toks": 77}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ◈ If a male takes temazepam, could it affect fertility (ability to get partner pregnant) or increase the chance of birth defects?\n\nStudies have not been done to see if temazepam could affect male fertility or increase the chance of birth defects above the background risk. In general, exposures that fathers or sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures at https://mothertobaby.org/fact-sheets/paternal-exposures-pregnancy/.\n\n11.1.8 Exposure Routes\n\nOral, well absorbed, minimal first-pass metabolism.\n\n11.1.9 Adverse Effects\n\nAdverse Drug Reactions\n\n\n                    Context: \n                    This section appears within the \"Toxicity\" and \"Adverse Effects\" portion of the temazepam compound page, specifically addressing reproductive safety concerns—here, the potential impact of male exposure to temazepam on fertility and risk of birth defects. It summarizes available research and provides general guidance for paternal exposures before transitioning to information about the drug's pharmacokinetics and adverse effects.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_54", "document_index": 65, "latency_s": 34.556679400004214, "prompt_toks": 17509, "completion_toks": 85}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    A post-marketing surveillance study was conducted to investigate the adverse effects of temazepam. The study included a sample of 10,057 patients who were administered a 40- to 60-mg dosage for 2 weeks and another group of 8043 patients who received the exact dosage for 3 months. The observed prevalence rate of hangovers in these patient groups was 7%. Furthermore, numerous adverse effects have been documented across various organ systems. Complaints about the cardiovascular system included palpitations, whereas gastrointestinal symptoms included xerostomia, dysgeusia, emesis, diarrhea, epigastric discomfort, and constipation. Neurological symptoms included headache, disorientation, drowsiness, dizziness, giddiness, unsteadiness, anterograde amnesia, and paresthesia. Commonly mentioned psychiatric symptoms included vivid dreams, nightmares, and depression. Temazepam can adversely impact social and mental health and cause violent outbursts at home and in public and psychological\n\n\n                    Context: \n                    This passage appears in the section detailing the adverse drug reactions and side effects of temazepam, summarizing findings from post-marketing surveillance studies about the prevalence and types of negative effects—such as hangovers, cardiovascular, gastrointestinal, neurological, and psychiatric symptoms—reported by patients after temazepam use. It provides real-world data on the safety profile of temazepam within the broader context of its pharmacology and toxicity.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_55", "document_index": 65, "latency_s": 36.990785500005586, "prompt_toks": 17345, "completion_toks": 62}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    psychiatric symptoms included vivid dreams, nightmares, and depression. Temazepam can adversely impact social and mental health and cause violent outbursts at home and in public and psychological disorders, including paranoia and other irrational behaviors.\n\n\n                    Context: \n                    This chunk is part of the \"Adverse Effects\" section detailing the range of negative psychological and behavioral side effects reported with temazepam use, including psychiatric symptoms such as vivid dreams, nightmares, depression, and more severe impacts on social and mental health like violent outbursts, paranoia, and irrational behavior.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_56", "document_index": 65, "latency_s": 33.90331419999711, "prompt_toks": 17424, "completion_toks": 95}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Drug-Drug Interactions\n\nThe concomitant administration of temazepam with opioid prescriptions, alcohol, or other CNS depressants can lead to significant drowsiness, respiratory depression, unconsciousness, and even fatality. Lingering effects on psychomotor and cognitive abilities may result in impaired driving ability and potentially higher risks of falling and hip fractures. Furthermore, the activity of temazepam can be disrupted by the concurrent use of barbiturates, nonselective monoamine oxidase inhibitors, phenothiazines, antipsychotics, skeletal muscle relaxants, and antihistamines.\n\n\n                    Context: \n                    This section discusses drug-drug interactions involving temazepam, highlighting potential risks and adverse effects when temazepam is taken with other medications such as opioids, alcohol, CNS depressants, barbiturates, monoamine oxidase inhibitors, antipsychotics, muscle relaxants, and antihistamines. It follows broader safety, toxicity, and adverse effect information and is part of the document's detailed guidance on the clinical use and risks associated with temazepam.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_57", "document_index": 65, "latency_s": 32.76664940000046, "prompt_toks": 17484, "completion_toks": 95}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    In relation to alcohol, a study compared blood concentrations of 80 to 100 mg/100 mL of ethanol with those of 20 mg and 30 mg of temazepam in terms of psychomotor speed, accuracy, and long-term memory. Ethanol and 30 mg of temazepam exhibited similar effects on information processing capacity and long-term memory formation. However, ethanol had a significantly distinct impact on psychomotor performance compared to temazepam, leading to faster but more error-prone behavior.\n\n11.1.10 Acute Effects\n\n11.1.11 Toxicity Data\n\nLD50: 1963 mg/kg (oral, mice) (L1338) LD50: 1833 mg/kg (oral, rat) (L1338) LD50: >2400 mg/kg (oral, rabbit) (L1338)\n\n11.1.12 Treatment\n\n\n                    Context: \n                    This section appears within the broader toxicity and adverse effects discussion for temazepam, specifically addressing acute effects and comparative toxicity data. It discusses the interaction of temazepam with alcohol, highlighting differences and similarities in psychomotor and cognitive effects compared to ethanol, then transitions into acute toxicity data (LD50 values) in animal models and recommended treatment protocols for overdose. This detail is part of a comprehensive safety and hazards overview to inform on temazepam's risks and clinical management.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_58", "document_index": 65, "latency_s": 36.44708419998642, "prompt_toks": 17548, "completion_toks": 104}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    11.1.10 Acute Effects\n\n11.1.11 Toxicity Data\n\nLD50: 1963 mg/kg (oral, mice) (L1338) LD50: 1833 mg/kg (oral, rat) (L1338) LD50: >2400 mg/kg (oral, rabbit) (L1338)\n\n11.1.12 Treatment\n\nIf the patient is conscious, vomiting should be induced mechanically or with emetics. Gastric lavage should be employed utilizing concurrently a cuffed endotracheal tube if the patient is unconscious to prevent aspiration and pulmonary complications. Maintenance of adequate pulmonary ventilation is essential. The use of pressor agents intravenously may be necessary to combat hypotension. Fluids should be administered intravenously to encourage diuresis. (L1712)\n\n11.1.13 Protein Binding\n\nIt has been recorded that about 96% of unchanged temazepam is bound to plasma proteins.\n\n12 Associated Disorders and Diseases\n\n13 Literature\n\n13.1 Consolidated References\n\n13.2 NLM Curated PubMed Citations\n\n13.3 Springer Nature References\n\n13.4 Thieme References\n\n13.5 Wiley References\n\n\n                    Context: \n                    This chunk appears in the \"Toxicity\" section of the document, immediately after detailed information on temazepam's toxicological effects, adverse reactions, and management of overdose. It provides specific data on acute toxicity (LD50 values in animals), outlines recommended treatments for temazepam overdose, and notes the high plasma protein binding of the drug. This section leads into subsequent topics on associated disorders, literature references, and further reading about the compound, serving as a bridge from toxicity handling to broader clinical and scientific context.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_59", "document_index": 65, "latency_s": 32.841824500006624, "prompt_toks": 17560, "completion_toks": 103}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    12 Associated Disorders and Diseases\n\n13 Literature\n\n13.1 Consolidated References\n\n13.2 NLM Curated PubMed Citations\n\n13.3 Springer Nature References\n\n13.4 Thieme References\n\n13.5 Wiley References\n\n13.6 Chemical Co-Occurrences in Literature\n\n13.7 Chemical-Gene Co-Occurrences in Literature\n\n13.8 Chemical-Disease Co-Occurrences in Literature\n\n14 Patents\n\nUS5211954\n\n14.1 Depositor-Supplied Patent Identifiers\n\nLink to all deposited patent identifiers\n\n14.2 WIPO PATENTSCOPE\n\nPatents are available for this chemical structure:\n\nhttps://patentscope.wipo.int/search/en/result.jsf?inchikey=SEQDDYPDSLOBDC-UHFFFAOYSA-N\n\n14.3 Chemical Co-Occurrences in Patents\n\n14.4 Chemical-Disease Co-Occurrences in Patents\n\n14.5 Chemical-Gene Co-Occurrences in Patents\n\n15 Interactions and Pathways\n\n15.1 Chemical-Target Interactions\n\n15.2 Drug-Drug Interactions\n\n15.3 Drug-Food Interactions\n\nAvoid alcohol.\n\nTake with or without food.\n\n16 Biological Test Results\n\n16.1 BioAssay Results\n\n17 Classification\n\n\n                    Context: \n                    This section of the document follows detailed information on temazepam's toxicity, safety, pharmacology, and clinical use. It presents data on associated disorders and diseases, references to scientific literature and patents, and provides information about molecular interactions, pathways, biological test results, and classification systems relevant to temazepam. This content serves as a resource for understanding the broader scientific, regulatory, and practical context of the compound, complementing the preceding sections that cover its properties, pharmacodynamics, therapeutic applications, and safety profile.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_60", "document_index": 65, "latency_s": 34.75217839999823, "prompt_toks": 17575, "completion_toks": 103}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    15.2 Drug-Drug Interactions\n\n15.3 Drug-Food Interactions\n\nAvoid alcohol.\n\nTake with or without food.\n\n16 Biological Test Results\n\n16.1 BioAssay Results\n\n17 Classification\n\n17.1 MeSH Tree\n\n17.2 NCI Thesaurus Tree\n\n17.3 ChEBI Ontology\n\n17.4 KEGG: USP\n\n17.5 KEGG: ATC\n\n17.6 KEGG: Target-based Classification of Drugs\n\n17.7 KEGG: Drug Groups\n\n17.8 KEGG: Drug Classes\n\n17.9 WHO ATC Classification System\n\n17.10 FDA Pharm Classes\n\n17.11 ChemIDplus\n\n17.12 ChEMBL Target Tree\n\n17.13 UN GHS Classification\n\n17.14 EPA CPDat Classification\n\n17.15 Drug Enforcement Administration (DEA) Classification\n\n17.16 NORMAN Suspect List Exchange Classification\n\n17.17 CCSBase Classification\n\n17.18 EPA DSSTox Classification\n\n17.19 International Agency for Research on Cancer (IARC) Classification\n\n17.20 FDA Drug Type and Pharmacologic Classification\n\n17.21 EPA Substance Registry Services Tree\n\n17.22 MolGenie Organic Chemistry Ontology\n\n17.23 Chemicals in PubChem from Regulatory Sources\n\n18 Information Sources\n\n\n                    Context: \n                    This chunk is located in the latter part of the document, following sections on temazepam’s pharmacology, metabolism, toxicity, safety data, and use. It begins by listing drug-drug and drug-food interactions, then transitions to the results of biological assays, and is followed by an extensive classification section that cross-references temazepam across various chemical, pharmacological, and regulatory taxonomies. This leads into the final section of the document, which details external information sources and databases relevant to temazepam.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_61", "document_index": 65, "latency_s": 34.72227430000203, "prompt_toks": 17569, "completion_toks": 87}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    17.21 EPA Substance Registry Services Tree\n\n17.22 MolGenie Organic Chemistry Ontology\n\n17.23 Chemicals in PubChem from Regulatory Sources\n\n18 Information Sources\n\nAustralian Industrial Chemicals Introduction Scheme (AICIS)\n\nLICENSE\n\nhttps://www.industrialchemicals.gov.au/copyright\n\n2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-\n\nhttps://services.industrialchemicals.gov.au/search-assessments/\n\nCAS Common Chemistry\n\nLICENSE\n\nThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.\n\nhttps://creativecommons.org/licenses/by-nc/4.0/\n\nTemazepam\n\nhttps://commonchemistry.cas.org/detail?cas_rn=846-50-4\n\nChemIDplus\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nTemazepam [USAN:USP:INN:BAN]\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/?source=chemidplus&sourceid=0000846504\n\nChemIDplus Chemical Information Classification\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/chemidplus\n\nDrugBank\n\nLICENSE\n\n\n                    Context: \n                    This section appears near the end of the document, immediately following detailed classifications and ontologies of temazepam from various chemical and regulatory authorities. It introduces the \"Information Sources\" segment, listing primary databases, organizations, and reference links where the chemical, regulatory, and safety information on temazepam throughout the document was obtained. This transition signals the shift from classification data to source attribution, supporting traceability and verification of the preceding content.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_62", "document_index": 65, "latency_s": 35.238155600003665, "prompt_toks": 17557, "completion_toks": 78}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    ChemIDplus Chemical Information Classification\n\nhttps://pubchem.ncbi.nlm.nih.gov/source/chemidplus\n\nDrugBank\n\nLICENSE\n\nCreative Common's Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/legalcode)\n\nhttps://www.drugbank.ca/legal/terms_of_use\n\nTemazepam\n\nhttps://www.drugbank.ca/drugs/DB00231\n\nDTP/NCI\n\nLICENSE\n\nUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.\n\nhttps://www.cancer.gov/policies/copyright-reuse\n\ntemazepam\n\nhttps://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=246303\n\nEPA DSSTox\n\nLICENSE\n\nhttps://www.epa.gov/privacy/privacy-act-laws-policies-and-resources\n\nTemazepam\n\nhttps://comptox.epa.gov/dashboard/DTXSID8021309\n\nCompTox Chemicals Dashboard Chemical Lists\n\nhttps://comptox.epa.gov/dashboard/chemical-lists/\n\nEuropean Chemicals Agency (ECHA)\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the temazepam compound page, listing external databases and resources (such as ChemIDplus, DrugBank, NCI, EPA DSSTox, and ECHA) that provide additional chemical, pharmacological, regulatory, and safety information about temazepam, along with associated licensing details and links for further reference.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_63", "document_index": 65, "latency_s": 34.490475600003265, "prompt_toks": 17502, "completion_toks": 83}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Temazepam\n\nhttps://comptox.epa.gov/dashboard/DTXSID8021309\n\nCompTox Chemicals Dashboard Chemical Lists\n\nhttps://comptox.epa.gov/dashboard/chemical-lists/\n\nEuropean Chemicals Agency (ECHA)\n\nLICENSE\n\nUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: \"Source: European Chemicals Agency, http://echa.europa.eu/\". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section of the document, which lists databases and external resources providing chemical, regulatory, and safety information about temazepam. It specifically references entries for temazepam in the CompTox Chemicals Dashboard and the European Chemicals Agency (ECHA), including their licensing terms, and is part of a comprehensive catalog of authoritative data repositories and their relevance to temazepam.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_64", "document_index": 65, "latency_s": 34.06468720000703, "prompt_toks": 17525, "completion_toks": 83}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://echa.europa.eu/web/guest/legal-notice\n\nTemazepam\n\nhttps://echa.europa.eu/substance-information/-/substanceinfo/100.011.535\n\nTemazepam (EC: 212-688-1)\n\nhttps://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/14306\n\nFDA Global Substance Registration System (GSRS)\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nTEMAZEPAM\n\nhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/CHB1QD2QSS\n\nHuman Metabolome Database (HMDB)\n\nLICENSE\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section near the end of the document, where external authoritative databases and resources related to temazepam are listed. It provides official links to chemical substance information on the ECHA (European Chemicals Agency), FDA Global Substance Registration, and Human Metabolome Database (HMDB), indicating where additional regulatory, chemical, and metabolomic data about temazepam can be found.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_65", "document_index": 65, "latency_s": 34.55869500001427, "prompt_toks": 17533, "completion_toks": 58}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.fda.gov/about-fda/about-website/website-policies#linking\n\nTEMAZEPAM\n\nhttps://gsrs.ncats.nih.gov/ginas/app/beta/substances/CHB1QD2QSS\n\nHuman Metabolome Database (HMDB)\n\nLICENSE\n\nHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.\n\nhttp://www.hmdb.ca/citing\n\nTemazepam\n\nhttp://www.hmdb.ca/metabolites/HMDB0014376\n\nHMDB0014376_msms_2226367\n\nhttps://hmdb.ca/metabolites/HMDB0014376#spectra\n\nNew Zealand Environmental Protection Authority (EPA)\n\nLICENSE\n\nThis work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section, listing external databases and resources related to temazepam, including licensing information and direct links to detailed chemical, pharmacological, and safety data (such as the FDA GSRS, Human Metabolome Database, and New Zealand EPA).\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_66", "document_index": 65, "latency_s": 37.65397800001665, "prompt_toks": 17535, "completion_toks": 91}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    New Zealand Environmental Protection Authority (EPA)\n\nLICENSE\n\nThis work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International licence.\n\nhttps://www.epa.govt.nz/about-this-site/general-copyright-statement/\n\nTemazepam\n\nhttps://www.epa.govt.nz/industry-areas/hazardous-substances/guidance-for-importers-and-manufacturers/hazardous-substances-databases/\n\nCalifornia Office of Environmental Health Hazard Assessment (OEHHA)\n\nTemazepam\n\nhttps://oehha.ca.gov/proposition-65/chemicals/temazepam\n\nChEBI\n\nTemazepam\n\nhttps://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:9435\n\nChEBI Ontology\n\nhttp://www.ebi.ac.uk/chebi/userManualForward.do#ChEBI%20Ontology\n\nDrug Enforcement Administration (DEA)\n\nLICENSE\n\nUnless otherwise indicated, information on Department of Justice websites is in the public domain and may be copied and distributed without permission. Citation of the Department of Justice as source of the information is appreciated, as appropriate.\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section of the document, listing external regulatory agencies and chemical databases relevant to temazepam. It provides official links to data and safety information from authorities such as the New Zealand EPA, California OEHHA, ChEBI, and the US DEA, as well as licensing terms for use of their content. This section supports verification and further research on temazepam by directing users to primary regulatory and scientific resources.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_67", "document_index": 65, "latency_s": 32.08401419999427, "prompt_toks": 17547, "completion_toks": 92}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.justice.gov/legalpolicies\n\nTemazepam\n\nhttps://www.deadiversion.usdoj.gov/schedules/\n\nDEA Drug and Chemical Classification\n\nhttps://www.dea.gov/drug-information/drug-scheduling\n\nFDA Pharm Classes\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nTEMAZEPAM\n\nhttps://dailymed.nlm.nih.gov/dailymed/browse-drug-classes.cfm\n\nFDA Pharmacological Classification\n\nhttps://www.fda.gov/industry/structured-product-labeling-resources/pharmacologic-class\n\nLiverTox\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nTemazepam\n\nhttps://www.ncbi.nlm.nih.gov/books/n/livertox/Temazepam/\n\nNCI Thesaurus (NCIt)\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section of the Temazepam compound page, listing authoritative databases, regulatory agencies, and scientific resources relevant to regulatory status, pharmacological classification, and safety data for temazepam. It provides links to the DEA drug schedule, FDA pharmacologic class, DailyMed, LiverTox, and the NCI Thesaurus, supporting users in finding legal, safety, and clinical classification information from government and research organizations.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_68", "document_index": 65, "latency_s": 35.2153524000023, "prompt_toks": 17516, "completion_toks": 63}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    LiverTox\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nTemazepam\n\nhttps://www.ncbi.nlm.nih.gov/books/n/livertox/Temazepam/\n\nNCI Thesaurus (NCIt)\n\nLICENSE\n\nUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.\n\nhttps://www.cancer.gov/policies/copyright-reuse\n\nhttps://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C29488\n\nNCI Thesaurus\n\nhttps://ncit.nci.nih.gov\n\nOpen Targets\n\nLICENSE\n\nDatasets generated by the Open Targets Platform are freely available for download.\n\nhttps://platform-docs.opentargets.org/licence\n\nTEMAZEPAM\n\nhttps://platform.opentargets.org/drug/CHEMBL967\n\nToxin and Toxin Target Database (T3DB)\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section near the end of the document, listing external data resources, licenses, and links related to temazepam from authoritative databases such as LiverTox, NCI Thesaurus, Open Targets, and Toxin and Toxin Target Database (T3DB).\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_69", "document_index": 65, "latency_s": 34.4399891999783, "prompt_toks": 17521, "completion_toks": 74}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://platform-docs.opentargets.org/licence\n\nTEMAZEPAM\n\nhttps://platform.opentargets.org/drug/CHEMBL967\n\nToxin and Toxin Target Database (T3DB)\n\nLICENSE\n\nT3DB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (T3DB) and the original publication.\n\nhttp://www.t3db.ca/downloads\n\nTemazepam\n\nhttp://www.t3db.ca/toxins/T3D2719\n\nCalifornia Safe Cosmetics Program (CSCP) Product Database\n\nLICENSE\n\nhttps://www.cdph.ca.gov/Pages/Conditions-of-Use.aspx\n\nTemazepam\n\nhttps://www.cdph.ca.gov/Programs/CCDPHP/DEODC/OHB/CSCP/Pages/About-CSCP.aspx\n\nCCSbase\n\nCCSbase Classification\n\nhttps://ccsbase.net/\n\nChEMBL\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the document, which lists databases and external resources related to temazepam. Each entry provides licensing terms and links to temazepam's profile or data in various chemical, toxicology, pharmaceutical, and regulatory databases. This contextual information helps users find authoritative external data sources relevant to temazepam.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_70", "document_index": 65, "latency_s": 34.0843540999922, "prompt_toks": 17563, "completion_toks": 64}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Temazepam\n\nhttps://www.cdph.ca.gov/Programs/CCDPHP/DEODC/OHB/CSCP/Pages/About-CSCP.aspx\n\nCCSbase\n\nCCSbase Classification\n\nhttps://ccsbase.net/\n\nChEMBL\n\nLICENSE\n\nAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).\n\nhttp://www.ebi.ac.uk/Information/termsofuse.html\n\nhttps://www.ebi.ac.uk/chembl/explore/compound/CHEMBL967\n\nChEMBL Protein Target Tree\n\nhttps://www.ebi.ac.uk/chembl/g/#browse/targets\n\nClinicalTrials.gov\n\nLICENSE\n\nThe ClinicalTrials.gov data carry an international copyright outside the United States and its Territories or Possessions. Some ClinicalTrials.gov data may be subject to the copyright of third parties; you should consult these entities for any additional terms of use.\n\nhttps://clinicaltrials.gov/ct2/about-site/terms-conditions#Use\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section near the end of the document, listing external databases, resources, and their licensing details for further information on temazepam, such as the California Safe Cosmetics Program, CCSbase, ChEMBL, and ClinicalTrials.gov, along with links and usage terms.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_71", "document_index": 65, "latency_s": 34.390225899987854, "prompt_toks": 17560, "completion_toks": 62}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://clinicaltrials.gov/ct2/about-site/terms-conditions#Use\n\nhttps://clinicaltrials.gov/\n\nComparative Toxicogenomics Database (CTD)\n\nLICENSE\n\nIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.\n\nhttp://ctdbase.org/about/legal.jsp\n\nTemazepam\n\nhttps://ctdbase.org/detail.go?type=chem&acc=D013693\n\nDrug Gene Interaction database (DGIdb)\n\nLICENSE\n\nThe data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.\n\nhttp://www.dgidb.org/downloads\n\nTEMAZEPAM\n\nhttps://www.dgidb.org/drugs/rxcui:10355\n\nTherapeutic Target Database (TTD)\n\nTemazepam\n\nhttps://idrblab.net/ttd/data/drug/details/D04BNP\n\nDailyMed\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nTEMAZEPAM\n\nhttps://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TEMAZEPAM\n\nNational Drug Code (NDC) Directory\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section, listing external databases and resources that provide additional information, data, or regulatory context for temazepam, including licensing terms and direct links to corresponding records in clinical trials, toxicogenomics, drug-gene interactions, therapeutic targets, and drug labeling directories.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_72", "document_index": 65, "latency_s": 35.62711629999103, "prompt_toks": 17500, "completion_toks": 66}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    DailyMed\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nTEMAZEPAM\n\nhttps://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=TEMAZEPAM\n\nNational Drug Code (NDC) Directory\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nTEMAZEPAM\n\nhttps://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory\n\nDrug Induced Liver Injury Rank (DILIrank) Dataset\n\nLICENSE\n\n\n                    Context: \n                    This chunk appears in the \"Information Sources\" section near the end of the document, listing major databases and official resources for further details on temazepam, including DailyMed, the FDA National Drug Code Directory, and the Drug Induced Liver Injury Rank (DILIrank) Dataset, along with associated licensing information and relevant URLs.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_73", "document_index": 65, "latency_s": 39.08406710001873, "prompt_toks": 17485, "completion_toks": 63}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    TEMAZEPAM\n\nhttps://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory\n\nDrug Induced Liver Injury Rank (DILIrank) Dataset\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\ntemazepam\n\nhttps://www.fda.gov/science-research/liver-toxicity-knowledge-base-ltkb/drug-induced-liver-injury-rank-dilirank-dataset\n\nStatPearls\n\nLICENSE\n\n\n                    Context: \n                    This chunk is from the \"Information Sources\" section of the full document, listing external databases and resources related to temazepam, including links to its entries in the FDA National Drug Code Directory, the Drug Induced Liver Injury Rank (DILIrank) Dataset, and StatPearls, along with licensing information.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_74", "document_index": 65, "latency_s": 31.31424869998591, "prompt_toks": 17567, "completion_toks": 73}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    temazepam\n\nhttps://www.fda.gov/science-research/liver-toxicity-knowledge-base-ltkb/drug-induced-liver-injury-rank-dilirank-dataset\n\nStatPearls\n\nLICENSE\n\nThis book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.\n\nTemazepam\n\nhttps://www.ncbi.nlm.nih.gov/books/n/statpearls/article-160552/\n\nNORMAN Suspect List Exchange\n\nLICENSE\n\nData: CC-BY 4.0; Code (hosted by ECI, LCSB): Artistic-2.0\n\nhttps://creativecommons.org/licenses/by/4.0/\n\nTEMAZEPAM\n\nNORMAN Suspect List Exchange Classification\n\nhttps://www.norman-network.com/nds/SLE/\n\nDrugs and Lactation Database (LactMed)\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nTemazepam\n\n\n                    Context: \n                    This chunk is from the \"Information Sources\" section of the document, listing external databases and resources related to temazepam, including their licensing information and relevant URLs. It follows the main sections on temazepam’s chemical properties, pharmacology, safety, and toxicity, and is part of a comprehensive bibliography and source/reference directory provided at the end of the page.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_75", "document_index": 65, "latency_s": 33.08870749999187, "prompt_toks": 17534, "completion_toks": 66}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    TEMAZEPAM\n\nNORMAN Suspect List Exchange Classification\n\nhttps://www.norman-network.com/nds/SLE/\n\nDrugs and Lactation Database (LactMed)\n\nLICENSE\n\nhttps://www.nlm.nih.gov/copyright.html\n\nTemazepam\n\nhttps://www.ncbi.nlm.nih.gov/books/n/lactmed/LM388/\n\nMother To Baby Fact Sheets\n\nLICENSE\n\nCopyright by OTIS. This work is available under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported license (CC BY-NC-ND 3.0).\n\nhttps://www.ncbi.nlm.nih.gov/books/about/copyright/\n\ntemazepam\n\nhttps://www.ncbi.nlm.nih.gov/books/n/mtb/temazepam-en/\n\nDrugs@FDA\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section near the end of the document, providing external resource links and license information for temazepam-related data, including regulatory, drug, and safety databases such as the NORMAN Suspect List Exchange, LactMed, Mother To Baby fact sheets, and Drugs@FDA.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_76", "document_index": 65, "latency_s": 34.55814609999652, "prompt_toks": 17552, "completion_toks": 80}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.fda.gov/about-fda/about-website/website-policies#linking\n\nTEMAZ\n\nhttps://www.accessdata.fda.gov/scripts/cder/daf/\n\nEPA Chemical and Products Database (CPDat)\n\nLICENSE\n\nhttps://www.epa.gov/privacy/privacy-act-laws-policies-and-resources\n\nhttps://comptox.epa.gov/dashboard/DTXSID8021309#exposure\n\nEPA CPDat Classification\n\nhttps://www.epa.gov/chemical-research/chemical-and-products-database-cpdat\n\nEU Clinical Trials Register\n\nhttps://www.clinicaltrialsregister.eu/\n\nFDA Medication Guides\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nRESTORIL\n\nhttps://dps.fda.gov/medguide\n\nFDA Orange Book\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the document, listing external databases, regulatory resources, and official agency links related to temazepam. It includes links for U.S. FDA resources, EPA chemical databases, the EU Clinical Trials Register, and FDA Medication Guides, providing sources for regulatory status, approvals, exposure data, and clinical information on temazepam.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_77", "document_index": 65, "latency_s": 34.71550130000105, "prompt_toks": 17543, "completion_toks": 75}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.fda.gov/about-fda/about-website/website-policies#linking\n\nRESTORIL\n\nhttps://dps.fda.gov/medguide\n\nFDA Orange Book\n\nLICENSE\n\nUnless otherwise noted, the contents of the FDA website (www.fda.gov), both text and graphics, are not copyrighted. They are in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from FDA. Credit to the U.S. Food and Drug Administration as the source is appreciated but not required.\n\nhttps://www.fda.gov/about-fda/about-website/website-policies#linking\n\nTEMAZEPAM\n\nhttps://www.fda.gov/drugs/drug-approvals-and-databases/approved-drug-products-therapeutic-equivalence-evaluations-orange-book\n\nNIST Mass Spectrometry Data Center\n\nLICENSE\n\nData covered by the Standard Reference Data Act of 1968 as amended.\n\nhttps://www.nist.gov/srd/public-law\n\nTemazepam\n\nhttp://www.nist.gov/srd/nist1a.cfm\n\nInternational Agency for Research on Cancer (IARC)\n\nLICENSE\n\n\n                    Context: \n                    This chunk appears within the \"Information Sources\" section of the document, which lists authoritative databases and regulatory resources related to temazepam. Here, it details official FDA and NIST resources for drug information and mass spectrometry data, as well as copyright and licensing policies, supporting the document's comprehensive reference framework for temazepam’s legal, regulatory, and scientific information.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_78", "document_index": 65, "latency_s": 36.412557300005574, "prompt_toks": 17543, "completion_toks": 58}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.nist.gov/srd/public-law\n\nTemazepam\n\nhttp://www.nist.gov/srd/nist1a.cfm\n\nInternational Agency for Research on Cancer (IARC)\n\nLICENSE\n\nMaterials made available by IARC/WHO enjoy copyright protection under the Berne Convention for the Protection of Literature and Artistic Works, under other international conventions, and under national laws on copyright and neighbouring rights. IARC exercises copyright over its Materials to make sure that they are used in accordance with the Agency's principles. All rights are reserved.\n\nhttps://publications.iarc.fr/Terms-Of-Use\n\nTemazepam\n\nhttps://monographs.iarc.who.int/list-of-classifications\n\nIARC Classification\n\nhttps://www.iarc.fr/\n\nJapan Chemical Substance Dictionary (Nikkaji)\n\nhttp://jglobal.jst.go.jp/en/redirect?Nikkaji_No=J7.138B\n\nKEGG\n\nLICENSE\n\nAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license\n\nhttps://www.kegg.jp/kegg/legal.html\n\nhttps://www.kegg.jp/entry/C07125\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section at the end of the full document, providing references and external resource links used for temazepam's chemical, regulatory, and scientific information, including data sources like NIST, IARC, Nikkaji, and KEGG.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_79", "document_index": 65, "latency_s": 32.6224813000008, "prompt_toks": 17589, "completion_toks": 60}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    KEGG\n\nLICENSE\n\nAcademic users may freely use the KEGG website. Non-academic use of KEGG generally requires a commercial license\n\nhttps://www.kegg.jp/kegg/legal.html\n\nhttps://www.kegg.jp/entry/C07125\n\nhttps://www.kegg.jp/entry/D00370\n\nUSP drug classification\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08302.keg\n\nAnatomical Therapeutic Chemical (ATC) classification\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08303.keg\n\nTarget-based classification of drugs\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08310.keg\n\nDrug Groups\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08330.keg\n\nDrug Classes\n\nhttp://www.genome.jp/kegg-bin/get_htext?br08332.keg\n\nMassBank Europe\n\nLICENSE\n\nhttps://github.com/MassBank/MassBank-web/blob/main/MassBank-Project/LICENSE.txt\n\nTemazepam\n\nhttps://massbank.eu/MassBank/Result.jsp?inchikey=SEQDDYPDSLOBDC-UHFFFAOYSA-N\n\nMassBank of North America (MoNA)\n\nLICENSE\n\nThe content of the MoNA database is licensed under CC BY 4.0.\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section, which lists external chemical, pharmacological, and spectral data resources related to temazepam. It provides licensing terms and direct links to authoritative databases such as KEGG, MassBank Europe, and MoNA for further reference and data access.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_80", "document_index": 65, "latency_s": 34.46266879999894, "prompt_toks": 17611, "completion_toks": 62}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Temazepam\n\nhttps://massbank.eu/MassBank/Result.jsp?inchikey=SEQDDYPDSLOBDC-UHFFFAOYSA-N\n\nMassBank of North America (MoNA)\n\nLICENSE\n\nThe content of the MoNA database is licensed under CC BY 4.0.\n\nhttps://mona.fiehnlab.ucdavis.edu/documentation/license\n\nTemazepam\n\nhttps://mona.fiehnlab.ucdavis.edu/spectra/browse?query=exists(compound.metaData.name:%27InChIKey%27%20and%20compound.metaData.value:%27SEQDDYPDSLOBDC-UHFFFAOYSA-N%27)\n\nSpectraBase\n\nCamazepam-M (temazepam) ##\n\nhttps://spectrabase.com/spectrum/6rU1NKevj2e\n\nTemazepam\n\nhttps://spectrabase.com/spectrum/6Vrbg46sOdL\n\nTemazepam\n\nhttps://spectrabase.com/spectrum/9AMpqWfSNZL\n\nTemazepam\n\nhttps://spectrabase.com/spectrum/Akf4QXlVxJn\n\nTemazepam\n\nhttps://spectrabase.com/spectrum/29UjKj0dFwK\n\nMetabolomics Workbench\n\nTemazepam\n\nhttps://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=42633\n\nNLM RxNorm Terminology\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section of the temazepam compound page, listing external databases and resources where spectral data and chemical information about temazepam are available, including links to MassBank, MoNA, SpectraBase, Metabolomics Workbench, and NLM RxNorm.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_81", "document_index": 65, "latency_s": 34.40008379999199, "prompt_toks": 17563, "completion_toks": 38}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Temazepam\n\nhttps://spectrabase.com/spectrum/29UjKj0dFwK\n\nMetabolomics Workbench\n\nTemazepam\n\nhttps://www.metabolomicsworkbench.org/data/StructureData.php?RegNo=42633\n\nNLM RxNorm Terminology\n\nLICENSE\n\nThe RxNorm Terminology is created by the National Library of Medicine (NLM) and is in the public domain and may be republished, reprinted and otherwise used freely by anyone without the need to obtain permission from NLM. Credit to the U.S. National Library of Medicine as the source is appreciated but not required. The full RxNorm dataset requires a free license.\n\nhttps://www.nlm.nih.gov/research/umls/rxnorm/docs/termsofservice.html\n\ntemazepam\n\nhttps://rxnav.nlm.nih.gov/id/rxnorm/10355\n\nPharmGKB\n\nLICENSE\n\nPharmGKB data are subject to the Creative Commons Attribution-ShareALike 4.0 license (https://creativecommons.org/licenses/by-sa/4.0/).\n\nhttps://www.pharmgkb.org/page/policies\n\ntemazepam\n\nhttps://www.pharmgkb.org/chemical/PA451608\n\nPharos\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section, listing databases and resources where temazepam data can be found, along with associated license information and relevant direct links for further reference.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_82", "document_index": 65, "latency_s": 35.409310199989704, "prompt_toks": 17559, "completion_toks": 92}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    https://www.pharmgkb.org/page/policies\n\ntemazepam\n\nhttps://www.pharmgkb.org/chemical/PA451608\n\nPharos\n\nLICENSE\n\nData accessed from Pharos and TCRD is publicly available from the primary sources listed above. Please respect their individual licenses regarding proper use and redistribution.\n\nhttps://pharos.nih.gov/about\n\ntemazepam\n\nhttps://pharos.nih.gov/ligands/Q4CA3TGL2PVD\n\nSpringer Nature\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/341141808\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/341191739\n\nThieme Chemistry\n\nLICENSE\n\nThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.\n\nhttps://creativecommons.org/licenses/by-nc-nd/4.0/\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/376723505\n\nUSGS Health-Based Screening Levels for Evaluating Water-Quality Data\n\nLICENSE\n\nhttps://www.usgs.gov/legal\n\nTemazepam\n\nhttps://water.usgs.gov/water-resources/hbsl/index.html\n\nWHO Anatomical Therapeutic Chemical (ATC) Classification\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the \"Information Sources\" section near the end of the Temazepam compound page. It lists external references, data repositories, and licensing information related to temazepam, such as PharmGKB, Pharos, Springer Nature, Thieme Chemistry, USGS, and the WHO ATC Classification. These links and citations provide access to additional data, external databases, and legal terms for using third-party information mentioned throughout the compound record.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_83", "document_index": 65, "latency_s": 34.58125480002491, "prompt_toks": 17521, "completion_toks": 83}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    LICENSE\n\nhttps://www.usgs.gov/legal\n\nTemazepam\n\nhttps://water.usgs.gov/water-resources/hbsl/index.html\n\nWHO Anatomical Therapeutic Chemical (ATC) Classification\n\nLICENSE\n\nUse of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed.\n\nhttps://www.whocc.no/copyright_disclaimer/\n\nTemazepam\n\nhttps://www.whocc.no/atc_ddd_index/?code=N05CD07\n\nEPA CPDat Classification\n\nhttps://www.whocc.no/atc_ddd_index/\n\nWikidata\n\nLICENSE\n\nCCZero\n\nhttps://creativecommons.org/publicdomain/zero/1.0/\n\ntemazepam\n\nhttps://www.wikidata.org/wiki/Q414796\n\nWikipedia\n\nTemazepam\n\nhttps://en.wikipedia.org/wiki/Temazepam\n\nWiley\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/386270862\n\nMedical Subject Headings (MeSH)\n\nLICENSE\n\n\n                    Context: \n                    This chunk is part of the comprehensive \"Information Sources\" section at the end of the document, listing authoritative external databases, classification systems, and licensing terms for temazepam. It provides links to resources such as the USGS, WHO ATC, Wikidata, and Wikipedia, which offer additional chemical, pharmacological, regulatory, and classification information about temazepam helpful for further research and cross-referencing.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_84", "document_index": 65, "latency_s": 34.60423639998771, "prompt_toks": 17553, "completion_toks": 87}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    Wikipedia\n\nTemazepam\n\nhttps://en.wikipedia.org/wiki/Temazepam\n\nWiley\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/386270862\n\nMedical Subject Headings (MeSH)\n\nLICENSE\n\nWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.\n\nhttps://www.nlm.nih.gov/copyright.html\n\nTemazepam\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68013693\n\nMeSH Tree\n\nhttp://www.nlm.nih.gov/mesh/meshhome.html\n\nGABA Modulators\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68018757\n\nHypnotics and Sedatives\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68006993\n\nAnti-Anxiety Agents\n\nhttps://www.ncbi.nlm.nih.gov/mesh/68014151\n\nPubChem\n\nhttps://pubchem.ncbi.nlm.nih.gov\n\nGHS Classification (UNECE)\n\nGHS Classification\n\nhttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html\n\nEPA Substance Registry Services\n\nLICENSE\n\n\n                    Context: \n                    This chunk appears within the \"Information Sources\" section of the document, listing authoritative external references and links relevant to temazepam, such as Wikipedia, Wiley, Medical Subject Headings (MeSH), PubChem, and various regulatory and classification resources. It follows the presentation of patent information and precedes further resource attributions, providing users with direct access to comprehensive databases, chemical ontologies, and official documentation for deeper research and verification.\n                "}
{"metadata": {"source": "pubchem", "title": "Temazepam | C16H13ClN2O2 | CID 5391 - PubChem", "description": "Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.", "language": "en", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5391", "drug": "Temazepam", "cid": 5391, "char_count": 62692, "word_count": 7523, "doc_id": "doc_65", "chunk_id": "65::chunk_85", "document_index": 65, "latency_s": 34.434864799986826, "prompt_toks": 17479, "completion_toks": 56}, "content": "Drug: Temazepam | cid: 5391\nSource: pubchem | Source description: Temazepam | C16H13ClN2O2 | CID 5391 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.\n\n                    Text: \n                    PubChem\n\nhttps://pubchem.ncbi.nlm.nih.gov\n\nGHS Classification (UNECE)\n\nGHS Classification\n\nhttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html\n\nEPA Substance Registry Services\n\nLICENSE\n\nhttps://www.epa.gov/privacy/privacy-act-laws-policies-and-resources\n\nEPA SRS List Classification\n\nhttps://maldi.nist.gov\n\nMolGenie\n\nLICENSE\n\nCC-BY 4.0\n\nhttps://creativecommons.org/licenses/by/4.0/\n\nMolGenie Organic Chemistry Ontology\n\nhttps://github.com/MolGenie/ontology/\n\nPATENTSCOPE (WIPO)\n\nSID 403424174\n\nhttps://pubchem.ncbi.nlm.nih.gov/substance/403424174\n\nNCBI\n\nhttps://www.ncbi.nlm.nih.gov/projects/linkout\n\n\n                    Context: \n                    This chunk is from the \"Information Sources\" section at the end of the document, which lists external databases, ontologies, legal notices, licensing information, and web links for further reference on temazepam, helping users locate authoritative resources for chemical, regulatory, and patent data.\n                "}
